| 1 |
Carmenate T, Montalvo G, Lozada SL, Rodriguez Y, Ortiz Y, Díaz C, Avellanet J, Kim J, Surh CD, Graça L, León K. The antitumor effect induced by an IL-2 ‘no-alpha’ mutein depends on changes in the CD8+ T lymphocyte/Treg cell balance. Front Immunol 2022;13:974188. [DOI: 10.3389/fimmu.2022.974188] [Reference Citation Analysis]
|
| 2 |
Holder PG, Lim SA, Huang CS, Sharma P, Dagdas YS, Bulutoglu B, Sockolosky JT. Engineering interferons and interleukins for cancer immunotherapy. Adv Drug Deliv Rev 2022;182:114112. [PMID: 35085624 DOI: 10.1016/j.addr.2022.114112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 3 |
Fernández-Ruiz M, Aguado JM. Direct T-cell Inhibition and Agents Targeting T-cell Migration and Chemotaxis. Infect Dis Clin North Am 2020;34:191-210. [PMID: 32334982 DOI: 10.1016/j.idc.2020.02.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Podichetty JT, Brinda BJ, Nelson RP, Karr AH, Prasad NK, Quinney S, Foxworthy Scott S, Kiel PJ. Pharmacokinetics of Basiliximab for the Prevention of Graft-versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplantation with Minimal-Intensity Cyclophosphamide and Fludarabine. Pharmacotherapy 2020;40:26-32. [PMID: 31742732 DOI: 10.1002/phar.2347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 5 |
Vazquez-Lombardi R, Loetsch C, Zinkl D, Jackson J, Schofield P, Deenick EK, King C, Phan TG, Webster KE, Sprent J, Christ D. Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells. Nat Commun 2017;8:15373. [PMID: 28497796 DOI: 10.1038/ncomms15373] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 6 |
Misu H, Takayama H, Saito Y, Mita Y, Kikuchi A, Ishii KA, Chikamoto K, Kanamori T, Tajima N, Lan F, Takeshita Y, Honda M, Tanaka M, Kato S, Matsuyama N, Yoshioka Y, Iwayama K, Tokuyama K, Akazawa N, Maeda S, Takekoshi K, Matsugo S, Noguchi N, Kaneko S, Takamura T. Deficiency of the hepatokine selenoprotein P increases responsiveness to exercise in mice through upregulation of reactive oxygen species and AMP-activated protein kinase in muscle. Nat Med 2017;23:508-16. [PMID: 28263310 DOI: 10.1038/nm.4295] [Cited by in Crossref: 101] [Cited by in F6Publishing: 100] [Article Influence: 16.8] [Reference Citation Analysis]
|
| 7 |
Ponce LF, García-Martínez K, León K. Quantitative Contribution of IL2Rγ to the Dynamic Formation of IL2-IL2R Complexes. PLoS One 2016;11:e0155684. [PMID: 27195783 DOI: 10.1371/journal.pone.0155684] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 8 |
Zaza G, Tomei P, Granata S, Boschiero L, Lupo A. Monoclonal antibody therapy and renal transplantation: focus on adverse effects. Toxins (Basel) 2014;6:869-91. [PMID: 24590384 DOI: 10.3390/toxins6030869] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 9 |
Kreitman RJ. Recombinant Immunotoxins. Cancer Drug Discovery and Development 2014. [DOI: 10.1007/978-1-4614-9135-4_29] [Reference Citation Analysis]
|
| 10 |
Ren T, Takahashi Y, Liu X, Loughran TP, Sun SC, Wang HG, Cheng H. HTLV-1 Tax deregulates autophagy by recruiting autophagic molecules into lipid raft microdomains. Oncogene 2015;34:334-45. [PMID: 24362528 DOI: 10.1038/onc.2013.552] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 11 |
Parker J, Sherman E, van de Raa M, van der Meer D, Samelson LE, Losert W. Automatic sorting of point pattern sets using Minkowski functionals. Phys Rev E Stat Nonlin Soft Matter Phys 2013;88:022720. [PMID: 24032877 DOI: 10.1103/PhysRevE.88.022720] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 12 |
Chianelli M, Malviya G, Glaudemans AW, Signore A. Nuclear Medicine Imaging of Inflammatory Diseases. Diagnostic Imaging of Infections and Inflammatory Diseases 2013. [DOI: 10.1002/9781118484388.ch17] [Reference Citation Analysis]
|
| 13 |
Mahalingam D, Brumlik MJ, Waehler R, Curiel DT, Curiel TJ. Targeted Toxins in Cancer Immunotherapy. Cancer Immunotherapy 2013. [DOI: 10.1007/978-1-4614-4732-0_12] [Reference Citation Analysis]
|
| 14 |
Ziegler I. TETRAHYDROBIOPTERIN SYNTHESIS IS TRIGGERED BY INTERLEUKIN 2 BINDING AND MODULATES RECEPTOR AFFINITY. Unconjugated pterins and related biogenic amines. [DOI: 10.1515/9783111503844.169] [Reference Citation Analysis]
|
| 15 |
Wilson CG, Arkin MR. Small-molecule inhibitors of IL-2/IL-2R: lessons learned and applied. Curr Top Microbiol Immunol 2011;348:25-59. [PMID: 20703966 DOI: 10.1007/82_2010_93] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Scott CS, Hunt KM, Jones RA, Gignac SM, Matutes E, Drexler HG. Proliferative Hairy Cell Leukaemia (HCL-v) Resistant to Alpha-Interferon: Clinical, Diagnostic and In-Vitro Cellular Characteristics. Leukemia & Lymphoma 2010;1:307-17. [DOI: 10.1080/10428199009169600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 17 |
Greene WC. An Overview of the Human Interleukin-2 Receptor: Molecular, Biochemical, and Functional Properties. Cancer Investigation 2010;5:369-76. [DOI: 10.1080/07357908709170110] [Reference Citation Analysis]
|
| 18 |
Kueng HJ, Manta C, Haiderer D, Leb VM, Schmetterer KG, Neunkirchner A, Byrne RA, Scheinecker C, Steinberger P, Seed B, Pickl WF. Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactions. FASEB J 2010;24:1572-82. [PMID: 20056716 DOI: 10.1096/fj.09-137281] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Kreitman RJ. Recombinant immunotoxins for the treatment of chemoresistant hematologic malignancies. Curr Pharm Des 2009;15:2652-64. [PMID: 19689336 DOI: 10.2174/138161209788923949] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 20 |
Delforge A, Bernier M, Bosmans E, Massy M, Bron D, Heyligen H, Raus J, Mendes Da Costa P, Stryckmans P. Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies. Leukemia & Lymphoma 2009;3:385-93. [DOI: 10.3109/10428199109070282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 21 |
Hoshino S, Oshimi K, Mizoguchi H. Interleukin-2 Receptor β Chain in Leukemias and Lymphomas. Leukemia & Lymphoma 2009;6:107-16. [DOI: 10.3109/10428199209064886] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 22 |
Kreitman RJ. Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies. BioDrugs 2009;23:1-13. [PMID: 19344187 DOI: 10.2165/00063030-200923010-00001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 23 |
Uemura Y, Taguchi T, Kubota T, Saito T, Bandobashi K, Yokoyama A. Neutrophil function and cytokine-specific signaling in chronic neutrophilic leukemia: NEUTROPHIL FUNCTION IN CNL. International Journal of Laboratory Hematology 2009;31:36-47. [DOI: 10.1111/j.1751-553x.2007.01000.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 24 |
Singh K, Shau H, Gupta R, Kopald K, Ray P. Protein A Potentiates Lymphokine-Activated Killer Cell Induction in Normal and Melanoma Patient Lymphocytes. Immunopharmacology and Immunotoxicology 2008;14:79-103. [DOI: 10.3109/08923979209009214] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 25 |
Wang H, Zhou CL, Lei H, Zhang SD, Zheng J, Wei Q. Kaempferol: a new immunosuppressant of calcineurin. IUBMB Life 2008;60:549-54. [PMID: 18506853 DOI: 10.1002/iub.94] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 26 |
Brumlik MJ, Daniel BJ, Waehler R, Curiel DT, Giles FJ, Curiel TJ. Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy. Expert Opinion on Drug Delivery 2007;5:87-103. [DOI: 10.1517/17425247.5.1.87] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 27 |
Amato R, Menniti M, Agosti V, Boito R, Costa N, Bond HM, Barbieri V, Tagliaferri P, Venuta S, Perrotti N. IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells. J Mol Med (Berl) 2007;85:707-21. [PMID: 17571248 DOI: 10.1007/s00109-007-0205-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 28 |
Ramirez CB, Marino IR. The role of basiliximab induction therapy in organ transplantation. Expert Opin Biol Ther. 2007;7:137-148. [PMID: 17150025 DOI: 10.1517/14712598.7.1.137] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 29 |
Koo H, Ryu SH, Ahn HJ, Jung WK, Park YK, Kwon NH, Kim SH, Kim JM, Yoo BW, Choi SI, Davis WC, Park YH. Immunostimulatory effects of the anionic alkali mineral complex Barodon on equine lymphocytes. Clin Vaccine Immunol 2006;13:1255-66. [PMID: 16943344 DOI: 10.1128/CVI.00150-06] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 30 |
Kreitman RJ. Immunotoxins for targeted cancer therapy. AAPS J 2006;8:E532-51. [PMID: 17025272 DOI: 10.1208/aapsj080363] [Cited by in Crossref: 203] [Cited by in F6Publishing: 222] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 31 |
Annovazzi A, Bonanno E, Arca M, D'Alessandria C, Marcoccia A, Spagnoli LG, Violi F, Scopinaro F, De Toma G, Signore A. 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur J Nucl Med Mol Imaging 2006;33:117-26. [PMID: 16220305 DOI: 10.1007/s00259-005-1899-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 32 |
Kreitman RJ. Recombinant toxins in haematologic malignancies and solid tumours. Expert Opin Investig Drugs 1998;7:1405-27. [PMID: 15992040 DOI: 10.1517/13543784.7.9.1405] [Reference Citation Analysis]
|
| 33 |
Kreitman RJ. Recombinant immunotoxins for the treatment of haematological malignancies. Expert Opinion on Biological Therapy 2005;4:1115-28. [DOI: 10.1517/14712598.4.7.1115] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 34 |
Mason NS, Lopresti BJ, Mathis CA. Imaging Inflammation. Measuring Immunity 2005. [DOI: 10.1016/b978-012455900-4/50301-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 35 |
Kuhn DJ, Dou QP. Direct inhibition of interleukin-2 receptor ?-mediated signaling pathway induces G1 arrest and apoptosis in human head-and-neck cancer cells. J Cell Biochem 2005;95:379-90. [DOI: 10.1002/jcb.20446] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 36 |
Kaplan D. Enzymatic amplification staining for single cell analysis: applied to in situ hybridization. Journal of Immunological Methods 2003;283:1-7. [DOI: 10.1016/j.jim.2003.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 37 |
Tournamille C, Filipe A, Wasniowska K, Gane P, Lisowska E, Cartron JP, Colin Y, Le Van Kim C. Structure-function analysis of the extracellular domains of the Duffy antigen/receptor for chemokines: characterization of antibody and chemokine binding sites. Br J Haematol 2003;122:1014-23. [PMID: 12956774 DOI: 10.1046/j.1365-2141.2003.04533.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 38 |
Kuhn DJ, Smith DM, Pross S, Whiteside TL, Dou QP. Overexpression of interleukin-2 receptor alpha in a human squamous cell carcinoma of the head and neck cell line is associated with increased proliferation, drug resistance, and transforming ability. J Cell Biochem 2003;89:824-36. [PMID: 12858347 DOI: 10.1002/jcb.10557] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 39 |
Adu D, Cockwell P, Ives NJ, Shaw J, Wheatley K. Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials. BMJ 2003;326:789. [PMID: 12689974 DOI: 10.1136/bmj.326.7393.789] [Cited by in Crossref: 104] [Cited by in F6Publishing: 113] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 40 |
Signore A, Picarelli A, Annovazzi A, Britton KE, Grossman AB, Bonanno E, Maras B, Barra D, Pozzilli P. 123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases. Nucl Med Commun 2003;24:305-16. [PMID: 12612472 DOI: 10.1097/00006231-200303000-00011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 41 |
Signore A, Annovazzi A, Corsetti F, Capriotti G, Chianelli M, De Winter F, Scopinaro F. Biological imaging for the diagnosis of inflammatory conditions. BioDrugs 2002;16:241-59. [PMID: 12196038 DOI: 10.2165/00063030-200216040-00002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 42 |
Massenkeil G, Rackwitz S, Genvresse I, Rosen O, Dörken B, Arnold R. Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Bone Marrow Transplant 2002;30:899-903. [PMID: 12476283 DOI: 10.1038/sj.bmt.1703737] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 43 |
Signore A, D'alessandria C, Annovazzi A, Scopinaro F. Radiolabelled cytokines for imaging chronic inflammation. Braz arch biol technol 2002;45:15-23. [DOI: 10.1590/s1516-89132002000500004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 44 |
Valles S, Caunt CJ, Walker MH, Qwarnstrom EE. PDGF enhancement of IL-1 receptor levels in smooth muscle cells involves induction of an attachment-regulated, heparan sulfate binding site (IL-1RIII). Lab Invest 2002;82:855-62. [PMID: 12118087 DOI: 10.1097/01.lab.0000020420.07575.3f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 45 |
Lundin K, Blomberg K, Nordström T, Lindqvist C. Development of a time-resolved fluorescence resonance energy transfer assay (cell TR-FRET) for protein detection on intact cells. Anal Biochem 2001;299:92-7. [PMID: 11726189 DOI: 10.1006/abio.2001.5370] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 46 |
Nashan B. The IL2 pathway in clinical immunosuppression. Transplant Proc 2001;33:3072-4. [PMID: 11750321 DOI: 10.1016/s0041-1345(01)02310-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 47 |
Horuk R, Shurey S, Ng HP, May K, Bauman JG, Islam I, Ghannam A, Buckman B, Wei GP, Xu W, Liang M, Rosser M, Dunning L, Hesselgesser J, Snider RM, Morrissey MM, Perez HD, Green C. CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model. Immunol Lett 2001;76:193-201. [PMID: 11306147 DOI: 10.1016/s0165-2478(01)00172-9] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 48 |
Azenabor AA, Hoffman-Goetz L. 17 beta-estradiol increases Ca(2+) influx and down regulates interleukin-2 receptor in mouse thymocytes. Biochem Biophys Res Commun 2001;281:277-81. [PMID: 11181041 DOI: 10.1006/bbrc.2001.4341] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 49 |
Signore A, Procaccini E, Annovazzi A, Chianelli M, van der Laken C, Mire-Sluis A. The developing role of cytokines for imaging inflammation and infection. Cytokine 2000;12:1445-54. [PMID: 11023659 DOI: 10.1006/cyto.2000.0746] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 50 |
Decker T, Schneller F, Kronschnabl M, Dechow T, Lipford GB, Wagner H, Peschel C. Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype. Exp Hematol 2000;28:558-68. [PMID: 10812246 DOI: 10.1016/s0301-472x(00)00144-2] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 51 |
Ehrhardt RO, Lúdvíksson BR. When immunization leads to autoimmunity: chronic inflammation as a result of thymic and mucosal dysregulation in IL-2 knock-out mice. Int Rev Immunol 1999;18:591-612. [PMID: 10672503 DOI: 10.3109/08830189909088500] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 52 |
Yazdanbakhsh K, Rios M, Storry JR, Kosower N, Parasol N, Chaudhuri A, Reid ME. Molecular mechanisms that lead to reduced expression of duffy antigens. Transfusion 2000;40:310-20. [PMID: 10738032 DOI: 10.1046/j.1537-2995.2000.40030310.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 53 |
Kreitman RJ. Chimeric toxins in cancer treatment. Emerging Drugs 2000;5:61-71. [DOI: 10.1517/14728214.5.1.61] [Reference Citation Analysis]
|
| 54 |
Reichert TE, Nagashima S, Kashii Y, Stanson J, Gao G, Dou QP, Whiteside TL. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression. Oncogene 2000;19:514-25. [PMID: 10698521 DOI: 10.1038/sj.onc.1203391] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 55 |
Papoff G, Hausler P, Eramo A, Pagano MG, Di Leve G, Signore A, Ruberti G. Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor. J Biol Chem 1999;274:38241-50. [PMID: 10608899 DOI: 10.1074/jbc.274.53.38241] [Cited by in Crossref: 125] [Cited by in F6Publishing: 126] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 56 |
Junghans RP. Cruel antibody fictions! Cellular antigen enumeration by 'saturation' binding. Immunol Today 1999;20:401-6. [PMID: 10532789 DOI: 10.1016/s0167-5699(97)01178-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 57 |
Lijnen P, Fagard R, Petrov V. Mibefradil-induced inhibition of proliferation of human peripheral blood mononuclear cells. J Cardiovasc Pharmacol 1999;33:595-604. [PMID: 10218730 DOI: 10.1097/00005344-199904000-00012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 58 |
Shanklin DR, Smalley DL. The immunopathology of siliconosis. History, clinical presentation, and relation to silicosis and the chemistry of silicon and silicone. Immunol Res 1998;18:125-73. [PMID: 9951648 DOI: 10.1007/BF02788777] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 59 |
Nashan B, Light S, Hardie IR, Lin A, Johnson JR. Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group. Transplantation 1999;67:110-5. [PMID: 9921806 DOI: 10.1097/00007890-199901150-00019] [Cited by in Crossref: 242] [Cited by in F6Publishing: 252] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 60 |
Thiagarajan D, Ram GC, Bansal MP. Optimum conditions for in vitro chicken IL-2 production and its in vivo role in Newcastle disease vaccinated chickens. Vet Immunol Immunopathol 1999;67:79-91. [PMID: 9950356 DOI: 10.1016/s0165-2427(98)00204-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 61 |
Honda M, Linker-israeli M. Cytokine Gene Expression in Human Systemic Lupus Erythematosus. Lupus 1999. [DOI: 10.1007/978-1-59259-703-1_21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 62 |
Kreitman RJ, Pastan I. Targeted Toxin Hybrid Proteins. Handbook of Experimental Pharmacology 1999. [DOI: 10.1007/978-3-642-59990-3_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 63 |
Baly DL, Horuk R, Yansura DG, Simmons LC, Fairbrother WJ, Kotts C, Wirth CM, Gillece-castro BL, Toy K, Hesselgesser J, Allison DE. A His19 to Ala Mutant of Melanoma Growth-Stimulating Activity Is a Partial Antagonist of the CXCR2 Receptor. The Journal of Immunology 1998;161:4944-4949. [DOI: 10.4049/jimmunol.161.9.4944] [Reference Citation Analysis]
|
| 64 |
Hong T, Matsumoto T, Kiyohara H, Yamada H. Enhanced production of hematopoietic growth factors through T cell activation in Peyer’s patches by oral administration of Kampo (Japanese herbal) medicine, “Juzen-Taiho-To”. Phytomedicine 1998;5:353-60. [DOI: 10.1016/s0944-7113(98)80017-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 65 |
Vieira J, Schall TJ, Corey L, Geballe AP. Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J Virol 1998;72:8158-65. [PMID: 9733857 DOI: 10.1128/JVI.72.10.8158-8165.1998] [Cited by in Crossref: 105] [Cited by in F6Publishing: 107] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 66 |
Hesselgesser J, Ng HP, Liang M, Zheng W, May K, Bauman JG, Monahan S, Islam I, Wei GP, Ghannam A, Taub DD, Rosser M, Snider RM, Morrissey MM, Perez HD, Horuk R. Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. J Biol Chem 1998;273:15687-92. [PMID: 9624164 DOI: 10.1074/jbc.273.25.15687] [Cited by in Crossref: 104] [Cited by in F6Publishing: 108] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 67 |
Vallesi A, Giuli G, Ghiara P, Scapigliati G, Luporini P. Structure-function relationships of pheromones of the ciliate Euplotes raikovi with mammalian growth factors: cross-reactivity between Er-1 and interleukin-2 systems. Exp Cell Res 1998;241:253-9. [PMID: 9633534 DOI: 10.1006/excr.1998.4056] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 68 |
Salard D, Kuzel TM, Samuelson E, Rosen S, Bakouche O. Interleukin-1 alpha increases the preferential cytotoxicity of an interleukin-2-diphtheria toxin fusion protein against neoplastic lymphocytes from patients with the Sezary syndrome compared to normal lymphocytes. J Clin Immunol 1998;18:223-34. [PMID: 9624582 DOI: 10.1023/a:1020587123523] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 69 |
Pastan I I, Kreitman RJ. Immunotoxins for targeted cancer therapy. Adv Drug Deliv Rev 1998;31:53-88. [PMID: 10837618 DOI: 10.1016/s0169-409x(97)00094-x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 99] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 70 |
Konigsberg PJ, Godtel R, Kissel T, Richer LL. The development of IL-2 conjugated liposomes for therapeutic purposes. Biochim Biophys Acta 1998;1370:243-51. [PMID: 9545572 DOI: 10.1016/s0005-2736(97)00269-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 71 |
Arima N, Matsushita K, Suruga Y, Ohtsubo H, Fujiwara H, Hidaka S, Arimura K, Kukita T, Yamaguchi K, Fukumori J, Tanaka H. IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-kappaB induction and IL-2 receptor alpha expression. Leuk Res 1998;22:265-73. [PMID: 9619918 DOI: 10.1016/s0145-2126(97)00168-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 72 |
Junghans RP, Carrasquillo JA, Waldmann TA. Impact of antigenemia on the bioactivity of infused anti-Tac antibody: implications for dose selection in antibody immunotherapies. Proc Natl Acad Sci U S A 1998;95:1752-7. [PMID: 9465089 DOI: 10.1073/pnas.95.4.1752] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 73 |
Hesselgesser J, Liang M, Hoxie J, Greenberg M, Brass LF, Orsini MJ, Taub D, Horuk R. Identification and Characterization of the CXCR4 Chemokine Receptor in Human T Cell Lines: Ligand Binding, Biological Activity, and HIV-1 Infectivity. The Journal of Immunology 1998;160:877-883. [DOI: 10.4049/jimmunol.160.2.877] [Reference Citation Analysis]
|
| 74 |
Horuk R, Hesselgesser J, Zhou Y, Faulds D, Halks-Miller M, Harvey S, Taub D, Samson M, Parmentier M, Rucker J, Doranz BJ, Doms RW. The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains. J Biol Chem 1998;273:386-91. [PMID: 9417093 DOI: 10.1074/jbc.273.1.386] [Cited by in Crossref: 125] [Cited by in F6Publishing: 131] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 75 |
Lin JX, Leonard WJ. Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev 1997;8:313-32. [PMID: 9620644 DOI: 10.1016/s1359-6101(97)00021-x] [Cited by in Crossref: 129] [Cited by in F6Publishing: 133] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 76 |
Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet 1997;350:1193-8. [PMID: 9652559 DOI: 10.1016/s0140-6736(97)09278-7] [Cited by in Crossref: 602] [Cited by in F6Publishing: 613] [Article Influence: 23.2] [Reference Citation Analysis]
|
| 77 |
Pastan I. Targeted therapy of cancer with recombinant immunotoxins. Biochim Biophys Acta 1997;1333:C1-6. [PMID: 9395287 DOI: 10.1016/s0304-419x(97)00021-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 22] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 78 |
Ehrhardt RO, Ludviksson B. Induction of colitis in IL2-deficient-mice: the role of thymic and peripheral dysregulation in the generation of autoreactive T cells. Res Immunol 1997;148:582-8. [PMID: 9588838 DOI: 10.1016/s0923-2494(98)80153-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 79 |
Chianelli M, Signore A, Fritzberg AR, Mather SJ. The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases. Nucl Med Biol 1997;24:579-86. [PMID: 9316088 DOI: 10.1016/s0969-8051(97)00021-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 80 |
Luo JS, Kammerer R, Schultze H, von Kleist S. Modulations of the effector function and cytokine production of human lymphocytes by secreted factors derived from colorectal-carcinoma cells. Int J Cancer 1997;72:142-8. [PMID: 9212235 DOI: 10.1002/(sici)1097-0215(19970703)72:1<142::aid-ijc20>3.0.co;2-k] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 81 |
Elg SA, Hill RB, Heldman L, Ramakrishnan S. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites. Gynecol Oncol 1997;66:133-7. [PMID: 9234933 DOI: 10.1006/gyno.1997.4741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 82 |
Tournamille C, Le Van Kim C, Gane P, Blanchard D, Proudfoot AE, Cartron JP, Colin Y. Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding. J Biol Chem 1997;272:16274-80. [PMID: 9195930 DOI: 10.1074/jbc.272.26.16274] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 83 |
Stenroos K, Hurskainen P, Blomberg K, Lindqvist C. Solid phase IL-2-IL-2R alpha assay with time resolved fluorometry. Immunol Lett 1997;58:15-8. [PMID: 9436463 DOI: 10.1016/s0165-2478(97)02719-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 84 |
Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Noguchi K, Hotta T, Mizobata S, Arii K. Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4. Br J Cancer 1996;74:1085-9. [PMID: 8855979 DOI: 10.1038/bjc.1996.494] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 85 |
Tsytsikov VN, Yurovsky VV, Atamas SP, Alms WJ, White B. Identification and characterization of two alternative splice variants of human interleukin-2. J Biol Chem 1996;271:23055-60. [PMID: 8798495 DOI: 10.1074/jbc.271.38.23055] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 86 |
Junghans RP, Anderson CL. The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci U S A 1996;93:5512-6. [PMID: 8643606 DOI: 10.1073/pnas.93.11.5512] [Cited by in Crossref: 523] [Cited by in F6Publishing: 543] [Article Influence: 19.4] [Reference Citation Analysis]
|
| 87 |
Chastagner P, Moreau JL, Jacques Y, Tanaka T, Miyasaka M, Kondo M, Sugamura K, Thèze J. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth. Eur J Immunol 1996;26:201-6. [PMID: 8566067 DOI: 10.1002/eji.1830260131] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 88 |
Lu ZH, Wang ZX, Horuk R, Hesselgesser J, Lou YC, Hadley TJ, Peiper SC. The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain. J Biol Chem 1995;270:26239-45. [PMID: 7592830 DOI: 10.1074/jbc.270.44.26239] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 89 |
Goldsmith MA, Lai SY, Xu W, Amaral MC, Kuczek ES, Parent LJ, Mills GB, Tarr KL, Longmore GD, Greene WC. Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and non-tyrosine residues of the gamma c chain. J Biol Chem 1995;270:21729-37. [PMID: 7665592 DOI: 10.1074/jbc.270.37.21729] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 90 |
Morishima I, Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, Ohki H, Suga T, Ito O. Serum levels of soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alpha. Scand J Gastroenterol 1995;30:807-11. [PMID: 7481551 DOI: 10.3109/00365529509096332] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 91 |
Mantovani G, Macciò A, Lai P, Ghiani M, Turnu E, Del Giacco GS. Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1 alpha, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies. Cell Biophys 1995;27:1-14. [PMID: 7493395 DOI: 10.1007/BF02822523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 92 |
Mallinson G, Soo KS, Schall TJ, Pisacka M, Anstee DJ. Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 1995;90:823-9. [PMID: 7669660 DOI: 10.1111/j.1365-2141.1995.tb05202.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 121] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 93 |
Hayashi J, Kishihara Y, Yamaji K, Yoshimura E, Ohmiya M, Tani Y, Ikematsu H, Kashiwagi S. Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus. Dig Dis Sci 1995;40:1837-41. [PMID: 7648988 DOI: 10.1007/BF02212710] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 94 |
Hesselgesser J, Chitnis CE, Miller LH, Yansura DG, Simmons LC, Fairbrother WJ, Kotts C, Wirth C, Gillece-Castro BL, Horuk R. A mutant of melanoma growth stimulating activity does not activate neutrophils but blocks erythrocyte invasion by malaria. J Biol Chem 1995;270:11472-6. [PMID: 7744785 DOI: 10.1074/jbc.270.19.11472] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 95 |
Peiper SC, Wang ZX, Neote K, Martin AW, Showell HJ, Conklyn MJ, Ogborne K, Hadley TJ, Lu ZH, Hesselgesser J, Horuk R. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995;181:1311-7. [PMID: 7699323 DOI: 10.1084/jem.181.4.1311] [Cited by in Crossref: 213] [Cited by in F6Publishing: 227] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 96 |
Greenway A, Azad A, McPhee D. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J Virol 1995;69:1842-50. [PMID: 7853525 DOI: 10.1128/JVI.69.3.1842-1850.1995] [Cited by in Crossref: 106] [Cited by in F6Publishing: 109] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 97 |
Kirman I, Nielsen OH, Kjaersgaard E, Brynskov J. Interleukin-2 receptor alpha and beta chain expression by circulating alpha beta and gamma delta T cells in inflammatory bowel disease. Dig Dis Sci 1995;40:291-5. [PMID: 7851192 DOI: 10.1007/BF02065412] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 98 |
Abdul-Hai A, Lorberboum-Gliski H, Mechushtan A, Weiss L, Slavin S, Or R. Involvement of interleukin-2 in immunologic reconstitution following bone marrow transplantation in mice. J Interferon Cytokine Res 1995;15:95-101. [PMID: 7648439 DOI: 10.1089/jir.1995.15.95] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 99 |
Eljaafari A, Dorval I, Soula M, Quelvennec E, Pirenne H, Fagard R, Sterkers G. Contribution of p56lck to the upregulation of cytokine production and T cell proliferation by IL-2 in human CD3-stimulated T cell clones. Cell Immunol 1995;160:152-6. [PMID: 7842481 DOI: 10.1016/0008-8749(95)80020-j] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 100 |
Fox FE, Chernajovsky Y, Platsoucas CD. Inhibition of interleukin 2 production and alteration of interleukin 2 mRNA processing by human T-T cell hybridoma-derived suppressor factors. Hybridoma 1994;13:343-52. [PMID: 7860090 DOI: 10.1089/hyb.1994.13.343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 101 |
Sparreboom A, Rongen H, van Bennekom W. Assays for interferons and interleukins in biological matrices. Analytica Chimica Acta 1994;295:1-26. [DOI: 10.1016/0003-2670(94)80330-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 102 |
W Kasinrerk, O Majdic, K Praputpittaya, N Sittisombut. Enhancement of human lymphocyte proliferative response to purified protein derivative by an anti-interleukin-2 receptor alpha chain antibody (CD25). Immunology 1994;83. [PMID: 7821963] [Reference Citation Analysis]
|
| 103 |
Horuk R, Wang Z, Peiper S, Hesselgesser J. Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line. Journal of Biological Chemistry 1994;269:17730-3. [DOI: 10.1016/s0021-9258(17)32501-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 104 |
Forsten KE, Lauffenburger DA. The role of low-affinity interleukin-2 receptors in autocrine ligand binding: alternative mechanisms for enhanced binding effect. Mol Immunol 1994;31:739-51. [PMID: 8035836 DOI: 10.1016/0161-5890(94)90148-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 105 |
Vlasveld LT, Rankin EM. Recombinant interleukin-2 in cancer: basic and clinical aspects. Cancer Treat Rev 1994;20:275-311. [PMID: 8020007 DOI: 10.1016/0305-7372(94)90004-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 106 |
Zorn U, Dallmann I, Grosse J, Kirchner H, Poliwoda H, Atzpodien J. Soluble interleukin 2 receptors abrogate IL-2 induced activation of peripheral mononuclear cells. Cytokine 1994;6:358-64. [PMID: 7948742 DOI: 10.1016/1043-4666(94)90058-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 107 |
Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994;13:2822-30. [PMID: 8026467 DOI: 10.1002/j.1460-2075.1994.tb06576.x] [Cited by in Crossref: 735] [Cited by in F6Publishing: 728] [Article Influence: 25.3] [Reference Citation Analysis]
|
| 108 |
J G Giri, M Ahdieh, J Eisenman, K Shanebeck, K Grabstein, S Kumaki, A Namen, L S Park, D Cosman, D Anderson. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994;13. [PMID: 8026467] [Reference Citation Analysis]
|
| 109 |
Fülöp T Jr. Signal transduction changes in granulocytes and lymphocytes with ageing. Immunol Lett 1994;40:259-68. [PMID: 7959894 DOI: 10.1016/0165-2478(94)00064-6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 110 |
Tilbery CP, Felipe E, Mota IM, Scheinberg MA. [Increase of interleukin-2 soluble receptors in multiple sclerosis: preliminary study in 26 patients]. Arq Neuropsiquiatr 1994;52:216-20. [PMID: 7826250 DOI: 10.1590/s0004-282x1994000200011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 111 |
Sliwkowski M, Schaefer G, Akita R, Lofgren J, Fitzpatrick V, Nuijens A, Fendly B, Cerione R, Vandlen R, Carraway K. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. Journal of Biological Chemistry 1994;269:14661-5. [DOI: 10.1016/s0021-9258(17)36676-0] [Cited by in Crossref: 487] [Cited by in F6Publishing: 243] [Article Influence: 16.8] [Reference Citation Analysis]
|
| 112 |
Oishi M, Johno M, Ono T, Honda M. Differences in IL-2 receptor levels between mycosis fungoides and cutaneous type adult T-cell leukemia/lymphoma in the early stages of the disease. J Invest Dermatol 1994;102:710-5. [PMID: 8176252 DOI: 10.1111/1523-1747.ep12374344] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 113 |
Goldsmith M, Xu W, Amaral M, Kuczek E, Greene W. The cytoplasmic domain of the interleukin-2 receptor beta chain contains both unique and functionally redundant signal transduction elements. Journal of Biological Chemistry 1994;269:14698-704. [DOI: 10.1016/s0021-9258(17)36681-4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 114 |
Roessler E, Grant A, Ju G, Tsudo M, Sugamura K, Waldmann TA. Cooperative interactions between the interleukin 2 receptor alpha and beta chains alter the interleukin 2-binding affinity of the receptor subunits. Proc Natl Acad Sci U S A 1994;91:3344-7. [PMID: 8159750 DOI: 10.1073/pnas.91.8.3344] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 115 |
Chang MP, Yamaguchi DT, Yeh M, Taylor AN, Norman DC. Mechanism of the impaired T-cell proliferation in adult rats exposed to alcohol in utero. Int J Immunopharmacol 1994;16:345-57. [PMID: 8045674 DOI: 10.1016/0192-0561(94)90010-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 116 |
Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994;179:973-84. [PMID: 7509366 DOI: 10.1084/jem.179.3.973] [Cited by in Crossref: 387] [Cited by in F6Publishing: 411] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 117 |
Chaudhuri A, Zbrzezna V, Polyakova J, Pogo A, Hesselgesser J, Horuk R. Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor. Journal of Biological Chemistry 1994;269:7835-8. [DOI: 10.1016/s0021-9258(17)37123-5] [Cited by in Crossref: 145] [Cited by in F6Publishing: 144] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 118 |
Berghella AM, Pellegrini P, Piancatelli D, Maccarone D, Del Beato T, Giubilei D, Pomidori A, Adorno D, Casciani CU. Progression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations. Cancer Immunol Immunother 1994;38:160-6. [PMID: 7907273 DOI: 10.1007/BF01525636] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 119 |
Forsten KE, Lauffenburger DA. Binding of Autocrine Interleukin-2 to Lymphocyte Surface Receptors. IFAC Proceedings Volumes 1994;27:155-158. [DOI: 10.1016/s1474-6670(17)46190-8] [Reference Citation Analysis]
|
| 120 |
Bulger K, Murphy J, Janckila A, Nichols J, McCaffrey R. Peripheral blood hairy cell leukemia cells express only low affinity IL-2 receptors. Leuk Res 1994;18:101-4. [PMID: 8107487 DOI: 10.1016/0145-2126(94)90125-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 121 |
Pollok KE, Kim YJ, Hurtado J, Zhou Z, Kim KK, Kwon BS. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur J Immunol 1994;24:367-74. [PMID: 8299685 DOI: 10.1002/eji.1830240215] [Cited by in Crossref: 175] [Cited by in F6Publishing: 179] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 122 |
R. Mukherjee, P. Chaturvedi, U. C. Chaturvedi. Specific receptors for dengue virus-induced suppressor cytokine on macrophages and lymphocytes. Int J Exp Pathol 1994;75. [PMID: 8142272] [Reference Citation Analysis]
|
| 123 |
Kreitman RJ, Pastan I. Recombinant toxins. Adv Pharmacol 1994;28:193-219. [PMID: 8080817 DOI: 10.1016/s1054-3589(08)60496-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 124 |
Matsumoto T, Iwasaki K. Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis. Ann Rheum Dis 1993;52:876-80. [PMID: 8311539 DOI: 10.1136/ard.52.12.876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 125 |
Fluckiger AC, Garrone P, Durand I, Galizzi JP, Banchereau J. Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J Exp Med 1993;178:1473-81. [PMID: 8228801 DOI: 10.1084/jem.178.5.1473] [Cited by in Crossref: 108] [Cited by in F6Publishing: 115] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 126 |
Tan J, Indelicato S, Narula S, Zavodny P, Chou C. Characterization of interleukin-10 receptors on human and mouse cells. Journal of Biological Chemistry 1993;268:21053-9. [DOI: 10.1016/s0021-9258(19)36892-9] [Cited by in Crossref: 111] [Cited by in F6Publishing: 110] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 127 |
A Rebollo, A Silva. Intermediate- and high-affinity interleukin-2 receptors expressed in an IL-4-dependent T-cell line induce different signals. Immunology 1993;80. [PMID: 8262551] [Reference Citation Analysis]
|
| 128 |
Hébert C, Chuntharapai A, Smith M, Colby T, Kim J, Horuk R. Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain. Journal of Biological Chemistry 1993;268:18549-53. [DOI: 10.1016/s0021-9258(17)46662-2] [Cited by in Crossref: 113] [Cited by in F6Publishing: 110] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 129 |
Barton DP, Blanchard DK, Michelini-Norris B, Roberts WS, Hoffman MS, Fiorica JV, Nicosia SV, Cavanagh D, Djeu JY. Serum soluble interleukin-2 receptor alpha levels in patients with gynecologic cancers: early effect of surgery. Am J Reprod Immunol 1993;30:202-6. [PMID: 8311929 DOI: 10.1111/j.1600-0897.1993.tb00621.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 130 |
Kullich W. Correlation of interleukin-2 receptor and neopterin secretion in rheumatoid arthritis. Clin Rheumatol 1993;12:387-91. [PMID: 8258242 DOI: 10.1007/BF02231585] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 131 |
Chang MP, Yamaguchi DT, Yeh M, Norman DC. Impaired cytosolic free calcium response in splenic T-cells from mice fed with ethanol-containing diet. Int J Immunopharmacol 1993;15:647-56. [PMID: 8407049 DOI: 10.1016/0192-0561(93)90137-n] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 132 |
A M Verhagen, M R Brandon, A D Nash. Characterization of the ovine interleukin-2 receptor-alpha chain: differential induction on precultured alpha beta and gamma delta T cells. Immunology 1993;79. [PMID: 8406574] [Reference Citation Analysis]
|
| 133 |
Cohen-Kaminsky S, Duquenoy JM, Berrih-Aknin S. Abnormal immunoregulation involving the IL-2/IL-2 receptor complex in myasthenia gravis. Ann N Y Acad Sci 1993;681:283-4. [PMID: 8357169 DOI: 10.1111/j.1749-6632.1993.tb22895.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 134 |
Sidorov IA, Romanyukha AA. Mathematical modeling of T-cell proliferation. Math Biosci 1993;115:187-232. [PMID: 8507990 DOI: 10.1016/0025-5564(93)90071-h] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 135 |
Zwierzina H. Practical aspects of cytokine therapy. Stem Cells 1993;11:144-53. [PMID: 8318903 DOI: 10.1002/stem.5530110301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 136 |
Zhu W, Igarashi T, Qi ZT, Newton C, Widen RE, Friedman H, Klein TW. delta-9-Tetrahydrocannabinol (THC) decreases the number of high and intermediate affinity IL-2 receptors of the IL-2 dependent cell line NKB61A2. Int J Immunopharmacol 1993;15:401-8. [PMID: 8389328 DOI: 10.1016/0192-0561(93)90051-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 137 |
Voss SD, Leary TP, Sondel PM, Robb RJ. Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A 1993;90:2428-32. [PMID: 7681595 DOI: 10.1073/pnas.90.6.2428] [Cited by in Crossref: 50] [Cited by in F6Publishing: 58] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 138 |
Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993;72:415-25. [PMID: 7679328 DOI: 10.1016/0092-8674(93)90118-a] [Cited by in Crossref: 579] [Cited by in F6Publishing: 622] [Article Influence: 19.3] [Reference Citation Analysis]
|
| 139 |
Mukherjee R, Chaturvedi P, Chaturvedi UC. Identification and purification of a receptor on macrophages for the dengue virus-induced suppressor cytokine. Clin Exp Immunol 1993;91:257-65. [PMID: 8381339 DOI: 10.1111/j.1365-2249.1993.tb05892.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 140 |
Isakov N. Tyrosine phosphorylation and dephosphorylation in T lymphocyte activation. Mol Immunol 1993;30:197-210. [PMID: 8429835 DOI: 10.1016/0161-5890(93)90092-p] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 141 |
Y Minami, T Kono, K Yamada, N Kobayashi, A Kawahara, R M Perlmutter, T Taniguchi. Association of p56lck with IL-2 receptor beta chain is critical for the IL-2-induced activation of p56lck. EMBO J 1993;12. [PMID: 8440263] [Reference Citation Analysis]
|
| 142 |
Gracheck SJ, Miller PF, Marks JS. Chapter 17. Recent Developments in Cell Based Mechanism Screens. Annual Reports in Medicinal Chemistry 1993. [DOI: 10.1016/s0065-7743(08)60887-8] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 143 |
Horuk R, Yansura D, Reilly D, Spencer S, Bourell J, Henzel W, Rice G, Unemori E. Purification, receptor binding analysis, and biological characterization of human melanoma growth stimulating activity (MGSA). Evidence for a novel MGSA receptor. Journal of Biological Chemistry 1993;268:541-6. [DOI: 10.1016/s0021-9258(18)54185-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 144 |
Kawami H, Yoshida K, Yamaguchi Y, Saeki T, Toge T. The expression and biological activity of IL-2 receptor on a human pancreas cancer cell line. Biotherapy 1993;6:33-9. [PMID: 8507543 DOI: 10.1007/BF01877384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 145 |
Miska W, Mahmoud M. Determination of soluble interleukin-2 receptor in human seminal plasma. Arch Androl 1993;30:23-8. [PMID: 8420501 DOI: 10.3109/01485019308988364] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 146 |
Carrasquillo J. Imaging and dosimetry determinations using radiolabeled antibodies. Cancer Treat Res 1993;68:65-97. [PMID: 8105853 DOI: 10.1007/978-1-4615-3076-3_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 147 |
Mantovani G, Macciò A, Astara G, Contini L, Esu S, Littera S, Arangino V, Lai P, Proto E, Pusceddu G. Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies. Cell Biophys 1993;22:79-99. [PMID: 7889544 DOI: 10.1007/BF03033868] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 148 |
Fernandes G, Venkatraman JT. Dietary Restriction Effects on Immunological Function and Aging. Nutrition and Immunology 1993. [DOI: 10.1007/978-1-4615-2900-2_5] [Reference Citation Analysis]
|
| 149 |
Foxwell B, Barrett K. Introduction to cytokine receptors: structure and signal transduction. Int Rev Exp Pathol 1993;34 Pt B:105-21. [PMID: 8384609 DOI: 10.1016/b978-0-12-364935-5.50012-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 150 |
Moon C, Mock M, Yang K, Han H, Won H, Kim J, Chung J, Moon C. Immunomodulating activities of brazilinin vitro. Arch Pharm Res 1992;15:283-8. [DOI: 10.1007/bf02974099] [Reference Citation Analysis]
|
| 151 |
Moon C, Mock M, Yang K, Lim C, Kim K, Chung J, Moon C. Brazilin inhibits mitogen induced cell proliferation despite of augmentation of T cell growth factor(TCGF) production and expression of IL-2 receptors. Arch Pharm Res 1992;15:275-82. [DOI: 10.1007/bf02974098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 152 |
Ridolfi R, Maltoni R, Riccobon A, Flamini E, Amadori D. Evaluation of toxicity in 22 patients treated with subcutaneous interleukin-2, alpha-interferon with and without chemotherapy. J Chemother 1992;4:394-8. [PMID: 1287142 DOI: 10.1080/1120009x.1992.11739198] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 153 |
Arima N, Kamio M, Imada K, Hori T, Hattori T, Tsudo M, Okuma M, Uchiyama T. Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling. J Exp Med 1992;176:1265-72. [PMID: 1402672 DOI: 10.1084/jem.176.5.1265] [Cited by in Crossref: 68] [Cited by in F6Publishing: 76] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 154 |
Liang SM, Lee N, Chen YY, Liang CM. Effects of glutathione on the synthesis and turnover of interleukin-2 receptors. Cell Immunol 1992;144:131-42. [PMID: 1394435 DOI: 10.1016/0008-8749(92)90231-d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 155 |
Stohl W, Elliott JE. Stimulation of human peripheral blood mononuclear cells with anti-CD3 monoclonal antibody vs IL2: disparate effects on T cell-dependent B cell differentiation despite similar effects on generation of unrestricted cytolytic activity. Clin Immunol Immunopathol 1992;65:30-8. [PMID: 1395122 DOI: 10.1016/0090-1229(92)90244-i] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 156 |
Ohno K, Goitsuka R, Kitamura K, Hasegawa A, Tokunaga T, Honda M. Production of a monoclonal antibody that defines the alpha-subunit of the feline IL-2 receptor. Hybridoma 1992;11:595-605. [PMID: 1459583 DOI: 10.1089/hyb.1992.11.595] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 157 |
Duprez V, Ferrer M, Dautry-varsat A. High-affinity interleukin 2 receptor alpha and beta chains are internalized and remain associated inside the cells after interleukin 2 endocytosis. Journal of Biological Chemistry 1992;267:18639-43. [DOI: 10.1016/s0021-9258(19)37008-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 158 |
Or R, Renz H, Terada N, Gelfand EW. IL-4 and IL-2 promote human T-cell proliferation through symmetrical but independent pathways. Clin Immunol Immunopathol 1992;64:210-7. [PMID: 1643754 DOI: 10.1016/0090-1229(92)90202-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 159 |
Elliott LH, Brooks WH, Roszman TL. Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor. J Neurooncol 1992;14:1-7. [PMID: 1335042 DOI: 10.1007/BF00170940] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 160 |
Bailey M, Stevens K, Bland PW, Stokes CR. A monoclonal antibody recognising an epitope associated with pig interleukin-2 receptors. J Immunol Methods 1992;153:85-91. [PMID: 1381406 DOI: 10.1016/0022-1759(92)90309-h] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 161 |
Célérier J, Cibert C, Barré-Sinoussi F, Ammar A, Jasmin C. Purification and identification of a CD25 expression inhibitory protein from cell-free supernatants of chronically HIV-infected promonocytic cells. Biochim Biophys Acta 1992;1139:300-6. [PMID: 1515455 DOI: 10.1016/0925-4439(92)90104-u] [Reference Citation Analysis]
|
| 162 |
Calvo V, Crews CM, Vik TA, Bierer BE. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc Natl Acad Sci U S A 1992;89:7571-5. [PMID: 1380162 DOI: 10.1073/pnas.89.16.7571] [Cited by in Crossref: 117] [Cited by in F6Publishing: 131] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 163 |
Voss SD, Sondel PM, Robb RJ. Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R. J Exp Med 1992;176:531-41. [PMID: 1500859 DOI: 10.1084/jem.176.2.531] [Cited by in Crossref: 89] [Cited by in F6Publishing: 102] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 164 |
Stosić-Grujicić S, Simić MM. In vitro effects of retinoid RO 10-9359 on lectin-induced activation and proliferation of T-lymphocytes. Int J Immunopharmacol 1992;14:903-14. [PMID: 1512081 DOI: 10.1016/0192-0561(92)90090-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 165 |
Wang H, Beckner SK. A colorimetric method for detection of specific ligand binding. Anal Biochem 1992;204:59-64. [PMID: 1325134 DOI: 10.1016/0003-2697(92)90139-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 166 |
Ammar A, Sahraoui Y, Tsapis A, Bertoli AM, Jasmin C, Georgoulias V. Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2. J Clin Invest 1992;90:8-14. [PMID: 1321845 DOI: 10.1172/JCI115859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 167 |
Carter CR, Hancock BW, Rees RC. The augmentation of lymphokine-activated killer activity following pulsing of human peripheral blood mononuclear cells with recombinant human interleukin-2. Cancer Immunol Immunother 1992;35:264-70. [PMID: 1511461 DOI: 10.1007/BF01789333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 168 |
Akasu F, Poplonski L, Snow KM, Volpe R, Keystone EC. Impaired generation of high-affinity interleukin-2 receptors in the autologous mixed lymphocyte reaction in rheumatoid arthritis. Clin Immunol Immunopathol 1992;63:142-7. [PMID: 1535295 DOI: 10.1016/0090-1229(92)90006-a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 169 |
Trochu JN, Denis M, Auget JL, Giral M, Jacques Y, Soulillou JP, Mauff B. Soluble interleukin 2 receptor (Tac chain) is not a reliable marker in kidney transplant recipient monitoring. Transplant Int 1992;5:145-50. [DOI: 10.1111/j.1432-2277.1992.tb01732.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 170 |
A M Verhagen, A E Andrews, M R Brandon, A D Nash. Molecular cloning, expression and characterization of the ovine IL-2R alpha chain. Immunology 1992;76. [PMID: 1628887] [Reference Citation Analysis]
|
| 171 |
Nakanishi K, Hirose S, Yoshimoto T, Ishizashi H, Hiroishi K, Tanaka T, Kono T, Miyasaka M, Taniguchi T, Higashino K. Role and regulation of interleukin (IL)-2 receptor alpha and beta chains in IL-2-driven B-cell growth. Proc Natl Acad Sci U S A 1992;89:3551-5. [PMID: 1373502 DOI: 10.1073/pnas.89.8.3551] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 172 |
Kreitman RJ, FitzGerald D, Pastan I. Targeting growth factor receptors with fusion toxins. Int J Immunopharmacol 1992;14:465-72. [PMID: 1319965 DOI: 10.1016/0192-0561(92)90177-m] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 173 |
de la Calle-Martín O, Alberola-Ila J, Engel P, Inglés J, Fabregat V, Barceló JJ, Lozano F, Gallart T. Impaired post-transcriptional expression of interleukin-2 receptor in pokeweed mitogen-activated T cells. Eur J Immunol 1992;22:897-902. [PMID: 1551406 DOI: 10.1002/eji.1830220403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 174 |
Dagli E, Warner JA, Besley CR, Warner JO. Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease. Arch Dis Child 1992;67:479-81. [PMID: 1580675 DOI: 10.1136/adc.67.4.479] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 175 |
Hatakeyama M, Kawahara A, Mori H, Shibuya H, Taniguchi T. c-fos gene induction by interleukin 2: identification of the critical cytoplasmic regions within the interleukin 2 receptor beta chain. Proc Natl Acad Sci U S A 1992;89:2022-6. [PMID: 1549560 DOI: 10.1073/pnas.89.6.2022] [Cited by in Crossref: 37] [Cited by in F6Publishing: 52] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 176 |
Ioannides CG, Fisk B, Tomasovic B, Pandita R, Aggarwal BB, Freedman RS. Induction of interleukin-2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytes. Cancer Immunol Immunother 1992;35:83-91. [PMID: 1534515 DOI: 10.1007/BF01741854] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 177 |
Godard A, Heymann D, Raher S, Anegon I, Peyrat M, Le Mauff B, Mouray E, Gregoire M, Virdee K, Soulillou J. High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution. Journal of Biological Chemistry 1992;267:3214-22. [DOI: 10.1016/s0021-9258(19)50718-9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 178 |
Sahraoui Y, Ammar A, Lunardi-Iskandar Y, Tsapis A, Spanakis E, N'Go N, Allouche M, Bellile VG, Jasmin C, Georgoulias V. Abnormal expression of IL-2R beta (p70)-binding polypeptide on HIV-infected patients' cells. Cell Immunol 1992;139:318-32. [PMID: 1733505 DOI: 10.1016/0008-8749(92)90074-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 179 |
Komada Y, Oitani K, Zhou YW, Zhang SL, Sakurai M. Expression of IL-2 receptor/p75 on lymphocytes from patients with rubella. Acta Paediatr Jpn 1992;34:12-6. [PMID: 1580147 DOI: 10.1111/j.1442-200x.1992.tb00918.x] [Reference Citation Analysis]
|
| 180 |
Neurath AR, Strick N, Sproul P. Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. J Exp Med 1992;175:461-9. [PMID: 1732412 DOI: 10.1084/jem.175.2.461] [Cited by in Crossref: 70] [Cited by in F6Publishing: 77] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 181 |
Schreiber S, Raedler A, Conn AR, Rombeau JL, MacDermott RP. Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease. Gut 1992;33:236-41. [PMID: 1541420 DOI: 10.1136/gut.33.2.236] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 182 |
Cortesina G, Sacchi M, Galeazzi E, Johnson JT, Whiteside TL. Interleukin 2 receptors on squamous cell carcinomas of the head and neck. Characterization and functional role. Acta Otolaryngol 1992;112:370-5. [PMID: 1605010 DOI: 10.1080/00016489.1992.11665436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 183 |
Pontzer CH, Griggs ND, Johnson HM. Interleukin 2. Advances in Neuroimmunology 1992;2:17-31. [DOI: 10.1016/s0960-5428(06)80003-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 184 |
Reem GH, Han X, Marcelli A. Regulation of IL-2 beta receptor expression and beta-chain mRNA by human thymocytes. Clin Exp Immunol 1992;87:150-6. [PMID: 1733630 DOI: 10.1111/j.1365-2249.1992.tb06429.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 185 |
Rebollo A, De Groote D, Baudrihay M, Thèze J, Jankovic DL. Immunochemical characterization of antigenic domains on human IL-2: Spatially distinct epitopes are associated with binding to the p55 and p70 subunits of IL-2 receptor. Molecular Immunology 1992;29:119-30. [DOI: 10.1016/0161-5890(92)90163-r] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 186 |
Gupta S. Interleukins. Immunopharmacology in Autoimmune Diseases and Transplantation 1992. [DOI: 10.1007/978-1-4899-1167-4_6] [Reference Citation Analysis]
|
| 187 |
Perelson AS, Goldstein B. Interaction of Interleukin-2 with its Cell Surface Receptors: Interpretation of Equilibrium Binding Experiments via Scatchard Plots. Theoretical and Experimental Insights into Immunology 1992. [DOI: 10.1007/978-3-642-76977-1_8] [Reference Citation Analysis]
|
| 188 |
Rose B, Gillespie A, Wunderlich D, Barbosa JA, Cahill K, Dzuiba J, Shedd D, Zerler B. A chimeric mouse/human anti-IL-2 receptor antibody with enhanced biological activities. Mol Immunol 1992;29:131-44. [PMID: 1731187 DOI: 10.1016/0161-5890(92)90164-s] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 189 |
Kahaleh MB, Yin TG. Enhanced expression of high-affinity interleukin-2 receptors in scleroderma: possible role for IL-6. Clin Immunol Immunopathol 1992;62:97-102. [PMID: 1728984 DOI: 10.1016/0090-1229(92)90028-m] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 190 |
Lother H, Müther H, Gessner A, Abdallah S, Kühlcke K. Intermolecular cystine-bonding of murine interleukin 2 indicates that ligand dimerization is important for the formation of the high-affinity receptor complex. Growth Factors 1992;7:117-29. [PMID: 1419069 DOI: 10.3109/08977199209046401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 191 |
Patel PM, Collins MK. Cytokine modulation of cell growth and role in tumour therapy. Eur J Cancer 1992;28:298-302. [PMID: 1567684 DOI: 10.1016/0959-8049(92)90439-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 192 |
Antonakis N, Markogiannakis E, Theodoropoulou M, Georgoulias V, Stournaras C, Gravanis A. The antiglucocorticoid RU486 downregulates the expression of interleukin-2 receptors in normal human lymphocytes. J Steroid Biochem Mol Biol 1991;39:929-35. [PMID: 1751392 DOI: 10.1016/0960-0760(91)90351-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 193 |
Mercken L, Moras V, Hemon L, Lionne B, Bousseau A, Dautry-Varsat A, Collins M, Mayaux JF. An exon 5-deleted mRNA encodes a functional interleukin 2 receptor alpha-subunit. Biochem Biophys Res Commun 1991;180:1390-5. [PMID: 1840490 DOI: 10.1016/s0006-291x(05)81350-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 194 |
Zwierzina H, Herold M, Schöllenberger S, Geissler D, Schmalzl F. Detection of soluble IL-2 receptor in the serum of patients with myelodysplastic syndromes: induction under therapy with GM-CSF. Br J Haematol 1991;79:438-43. [PMID: 1751371 DOI: 10.1111/j.1365-2141.1991.tb08052.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 195 |
Shenoy AM, Brahmi Z. Inhibition of the calpain-mediated proteolysis of protein kinase C enhances lytic activity in human NK cells. Cell Immunol 1991;138:24-34. [PMID: 1913839 DOI: 10.1016/0008-8749(91)90129-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 196 |
Augustine JA, Sutor SL, Abraham RT. Interleukin 2- and polyomavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes. Mol Cell Biol 1991;11:4431-40. [PMID: 1652056 DOI: 10.1128/mcb.11.9.4431-4440.1991] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 197 |
Kosmas C, Epenetos AA, Courtenay-Luck NS. Patients receiving murine monoclonal antibody therapy for malignancy develop T cells that proliferate in vitro in response to these antibodies as antigens. Br J Cancer 1991;64:494-500. [PMID: 1911190 DOI: 10.1038/bjc.1991.337] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 198 |
Rand TH, Silberstein DS, Kornfeld H, Weller PF. Human eosinophils express functional interleukin 2 receptors. J Clin Invest 1991;88:825-32. [PMID: 1885772 DOI: 10.1172/JCI115383] [Cited by in Crossref: 95] [Cited by in F6Publishing: 105] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 199 |
Augustine JA, Sutor SL, Abraham RT. Interleukin 2- and polyomavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes. Mol Cell Biol 1991;11:4431-40. [PMID: 1652056 DOI: 10.1128/mcb.11.9.4431-4440.1991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 19] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 200 |
Remillard B, Petrillo R, Maslinski W, Tsudo M, Strom T, Cantley L, Varticovski L. Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. Journal of Biological Chemistry 1991;266:14167-70. [DOI: 10.1016/s0021-9258(18)98660-6] [Cited by in Crossref: 116] [Cited by in F6Publishing: 111] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 201 |
Takemoto H, Yagi H, Harada M, Ide M. Two distinct P70 interleukin-2 receptors on a murine large granular lymphocyte clone Y479. Immunol Invest 1991;20:461-74. [PMID: 1791035 DOI: 10.3109/08820139109082627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 202 |
Levitt LJ, Nagler A, Lee F, Abrams J, Shatsky M, Thompson D. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor. J Clin Invest 1991;88:67-75. [PMID: 1676038 DOI: 10.1172/JCI115306] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 203 |
Hatakeyama M, Kono T, Kobayashi N, Kawahara A, Levin SD, Perlmutter RM, Taniguchi T. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association. Science 1991;252:1523-8. [PMID: 2047859 DOI: 10.1126/science.2047859] [Cited by in Crossref: 410] [Cited by in F6Publishing: 492] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 204 |
Burdach S, Zessack N, Dilloo D, Shatsky M, Thompson D, Levitt L. Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor. J Clin Invest 1991;87:2114-21. [PMID: 1828253 DOI: 10.1172/JCI115242] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 205 |
A Myc, P DeAngelis, P Lassota, M R Melamed, Z Darzynkiewicz. Effect of swainsonine on interleukin-2 alpha chain receptor expression and proliferation of human lymphocytes. Clin Exp Immunol 1991;84. [PMID: 1904326] [Reference Citation Analysis]
|
| 206 |
Plumas J, Gruart V, Aldebert D, Truong MJ, Capron M, Capron A, Prin L. Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 interleukin 2 receptor subunit. Eur J Immunol 1991;21:1265-70. [PMID: 2037012 DOI: 10.1002/eji.1830210525] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 207 |
Cunningham BC, Wells JA. Rational design of receptor-specific variants of human growth hormone. Proc Natl Acad Sci U S A 1991;88:3407-11. [PMID: 2014261 DOI: 10.1073/pnas.88.8.3407] [Cited by in Crossref: 145] [Cited by in F6Publishing: 153] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 208 |
Kesson AM, Bryson YJ. Uptake of Extracellular Ca 2+ Is a Requirement for Production of Interferon-γ by Cord Blood Mononuclear Cells. Journal of Interferon Research 1991;11:81-6. [DOI: 10.1089/jir.1991.11.81] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 209 |
Vibe-Petersen J, Tvede N, Diamant M, Kjerulff AA, Sørensen HR, Andersen V. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer. Cancer Immunol Immunother 1991;33:121-7. [PMID: 1903673 DOI: 10.1007/BF01742540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 210 |
Chu JW, Sharom FJ. Effect of micellar and bilayer gangliosides on proliferation of interleukin-2-dependent lymphocytes. Cell Immunol 1991;132:319-38. [PMID: 1988158 DOI: 10.1016/0008-8749(91)90031-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 211 |
Bentin J, Koutsoukos M, Pierart M, Appelboom T, Ceuppens JL. Polymorphonuclear neutrophils enhance anti-CD3-induced T cell activation: the role of polymorphonuclear FC-receptors. Cell Immunol 1991;132:339-49. [PMID: 1824828 DOI: 10.1016/0008-8749(91)90032-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 212 |
Waldmann TA. The interleukin-2 receptor. Journal of Biological Chemistry 1991;266:2681-4. [DOI: 10.1016/s0021-9258(18)49895-x] [Cited by in Crossref: 209] [Cited by in F6Publishing: 118] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 213 |
End P, Engel J. Multidomain Proteins of the Extracellular Matrix and Cellular Growth. Receptors for Extracellular Matrix. Elsevier; 1991. pp. 79-129. [DOI: 10.1016/b978-0-12-483365-4.50008-6] [Cited by in Crossref: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 214 |
Duprez V, Ferrer M, Cornet V, Olive D, Dautry-varsat A. Modulation of interleukin 2 internalization and interleukin 2-dependent cell growth by antireceptor antibodies. Journal of Biological Chemistry 1991;266:1497-501. [DOI: 10.1016/s0021-9258(18)52322-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 215 |
Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991;173:79-87. [PMID: 1985127 DOI: 10.1084/jem.173.1.79] [Cited by in Crossref: 230] [Cited by in F6Publishing: 238] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 216 |
Thies JC, Otto G, Kraus T, Meuer S, Hofmann WJ, Herfarth C. Wirksame Unterdrückung der Abstoßungsreaktion nach Lebertransplantation durch einen neuen monoklonalen Antikörper BT 563. Chirurgisches Forum ’91 für experimentelle und klinische Forschung 1991. [DOI: 10.1007/978-3-642-76513-1_12] [Reference Citation Analysis]
|
| 217 |
Horuk R. Differences in internalization and intracellular processing of interleukin-1 associated with the two forms of interleukin-1 receptor found in B-cells and T-cells. Biochem J 1991;273(Pt 1):79-83. [PMID: 1824916 DOI: 10.1042/bj2730079] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 218 |
Yamada S, Ichikawa M, Komiyama A. Impaired Cytotoxic Activity of Interleukin 2 (IL 2)-cultured Large Granular Lymphocytes (LGL) in Childhood Acute Lymphoblastic Leukemia. Quantitative Measurement of IL 2 Receptor Expression of IL 2-cultured LGL. Leuk Lymphoma 1991;6:65-73. [PMID: 27457578 DOI: 10.3109/10428199109064881] [Reference Citation Analysis]
|
| 219 |
Chopra V, Tyring SK. Suppression of interleukin-2 production and activity by factor(s) released by peripheral blood mononuclear cells during papillomavirus infections. Viral Immunol 1991;4:237-48. [PMID: 1668059 DOI: 10.1089/vim.1991.4.237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 220 |
Freedman AS. Cell Surface Markers in Leukemia and Lymphoma. In: Harris JR, editor. Blood Cell Biochemistry Volume 3. Boston: Springer US; 1991. pp. 33-71. [DOI: 10.1007/978-1-4615-3796-0_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 221 |
Shackelford DA, Trowbridge IS. Ligand-stimulated tyrosine phosphorylation of the IL-2 receptor beta chain and receptor-associated proteins. Cell Regul 1991;2:73-85. [PMID: 2007186 DOI: 10.1091/mbc.2.1.73] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 222 |
Freedman AS, Pedrazzini A, Nadler LM. B-cell monoclonal antibodies and their use in clinical oncology. Cancer Invest 1991;9:69-84. [PMID: 2012999 DOI: 10.3109/07357909109032802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 223 |
Ichikawa M, Tsudo M. Impaired expression of interleukin 2 receptors in childhood acute lymphoblastic leukemia. Leuk Res 1991;15:591-5. [PMID: 1861542 DOI: 10.1016/0145-2126(91)90027-q] [Reference Citation Analysis]
|
| 224 |
Cordero OJ, Sarandeses CS, López JL, Cancio E, Regueiro BJ, Nogueira M. Prothymosin alpha enhances interleukin 2 receptor expression in normal human T-lymphocytes. Int J Immunopharmacol 1991;13:1059-65. [PMID: 1814846 DOI: 10.1016/0192-0561(91)90156-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 225 |
Harvey W, Srour EF, Turner R, Carey R, Maze R, Starrett B, Kanagala R, Pereira D, Merchant P, Taylor M. Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogene regulation and late B-cell differentiation. Leuk Res 1991;15:733-44. [PMID: 1895754 DOI: 10.1016/0145-2126(91)90077-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 226 |
Ofosu-Appiah W, Mokhtarian F, Miller A, Grob D. Characterization of in vivo-activated T cell clones from peripheral blood of multiple sclerosis patients. Clin Immunol Immunopathol 1991;58:46-55. [PMID: 1701373 DOI: 10.1016/0090-1229(91)90147-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 227 |
Mevissen ML, de Boer M, Tuin K, Tager JM, de Groot C. Identification of structural differences between different forms of interleukin-2 (IL-2) using anti-(human recombinant) IL-2 monoclonal antibodies. Cytokine 1991;3:54-9. [PMID: 1715771 DOI: 10.1016/1043-4666(91)90010-b] [Reference Citation Analysis]
|
| 228 |
K Taga, Y Kasahara, A Yachie, T Miyawaki, N Taniguchi. Preferential expression of IL-2 receptor subunits on memory populations within CD4+ and CD8+ T cells. Immunology 1991;72. [PMID: 1900055] [Reference Citation Analysis]
|
| 229 |
W. E. Beschorner, K. Baughman, R. P. Turnicky, G. M. Hutchins, S. A. Rowe, A. L. Kavanaugh-McHugh, D. L. Suresch, A. Herskowitz. HIV-associated myocarditis. Pathology and immunopathology. Am J Pathol 1990;137. [PMID: 2260626] [Reference Citation Analysis]
|
| 230 |
Pomier G, Vindimian M, Healy JC, Le Petit JC. Increased interleukin-2 receptor affinity in normal HLA A1 B8 DR3 subjects. J Immunogenet 1990;17:371-7. [PMID: 2096181 DOI: 10.1111/j.1744-313x.1990.tb00888.x] [Reference Citation Analysis]
|
| 231 |
Dobbelaere DA, Prospero TD, Roditi IJ, Kelke C, Baumann I, Eichhorn M, Williams RO, Ahmed JS, Baldwin CL, Clevers H. Expression of Tac antigen component of bovine interleukin-2 receptor in different leukocyte populations infected with Theileria parva or Theileria annulata. Infect Immun 1990;58:3847-55. [PMID: 1979317 DOI: 10.1128/iai.58.12.3847-3855.1990] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 232 |
Y Yamamura, M Kotani, M Tsudo, H Karasuyama, A Seto, M Miyasaka. IL-2 receptors on rabbit T-cell lines and their transfectants expressing the human IL-2 receptor alpha chain. Immunology 1990;71. [PMID: 2279736] [Reference Citation Analysis]
|
| 233 |
Haynes L, Moynihan JA, Cohen N. A monoclonal antibody against the human IL-2 receptor binds to paraformaldehyde-fixed but not viable frog (Xenopus) splenocytes. Immunol Lett 1990;26:227-32. [PMID: 2086450 DOI: 10.1016/0165-2478(90)90151-f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 234 |
Cohen N, Stempel C, Colombe B, Garovoy M. Soluble interleukin-2 receptor: Detection and potential role in organ transplantation. Clinical Immunology Newsletter 1990;10:175-81. [DOI: 10.1016/0197-1859(90)90006-t] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 235 |
Miossec P, Elhamiani M, Edmonds-Alt X, Sany J, Hirn M. Functional studies of soluble low-affinity interleukin-2 receptors in rheumatoid synovial fluid. Arthritis Rheum 1990;33:1688-94. [PMID: 2242065 DOI: 10.1002/art.1780331112] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 236 |
Hüsken D, Beckers T, Engels JW. Overexpression in Escherichia coli of a methionine-free designed interleukin-2 receptor (Tac protein) based on a chemically cleavable fusion protein. Eur J Biochem 1990;193:387-94. [PMID: 2121481 DOI: 10.1111/j.1432-1033.1990.tb19351.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 237 |
Nakamura M, Ogawa H, Tsunematsu T. Characterization of cell-surface receptors for monoclonal-nonspecific suppressor factor (MNSF). Cell Immunol 1990;130:281-90. [PMID: 2208300 DOI: 10.1016/0008-8749(90)90271-r] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 238 |
Pócsik E, Mihalik R, Gyódi E, Réti M, Pálóczi K, Petrányi GG, Benczúr M. Activation of lymphocytes after platelet allotransfusion possessing only class I MHC product. Clin Exp Immunol 1990;82:102-7. [PMID: 1976462 DOI: 10.1111/j.1365-2249.1990.tb05411.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 239 |
Zielinski CC, Pesau B, Müller C. Soluble interleukin-2 receptor and soluble CD8 antigen in active rheumatoid arthritis. Clin Immunol Immunopathol 1990;57:74-82. [PMID: 2118434 DOI: 10.1016/0090-1229(90)90023-j] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 240 |
Mauff BL, Cantarovich D, Jacques Y, Soulillou J. Monoclonal antibodies against interleukin-2 receptors in the immunosuppressive management of kidney graft recipients. Transplantation Reviews 1990;4:79-92. [DOI: 10.1016/s0955-470x(11)80007-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 241 |
Voss SD, Robb RJ, Weil-Hillman G, Hank JA, Sugamura K, Tsudo M, Sondel PM. Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding. J Exp Med 1990;172:1101-14. [PMID: 1698909 DOI: 10.1084/jem.172.4.1101] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 242 |
Mannel DN, Falk W, Yron I. Inhibition of murine cytotoxic T cell responses by progesterone. Immunol Lett 1990;26:89-94. [PMID: 2148927 DOI: 10.1016/0165-2478(90)90181-o] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 243 |
Giri JG, Newton RC, Horuk R. Identification of soluble interleukin-1 binding protein in cell-free supernatants. Evidence for soluble interleukin-1 receptor. Journal of Biological Chemistry 1990;265:17416-9. [DOI: 10.1016/s0021-9258(18)38176-6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 244 |
Burton J, Goldman CK, Rao P, Moos M, Waldmann TA. Association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin 2 receptor. Proc Natl Acad Sci U S A 1990;87:7329-33. [PMID: 1976256 DOI: 10.1073/pnas.87.18.7329] [Cited by in Crossref: 42] [Cited by in F6Publishing: 52] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 245 |
Chow CC, Lai KN, Leung JC, Chan JC, Cockram CS. Serum soluble interleukin 2 receptor in hyperthyroid Graves' disease and effect of carbimazole therapy. Clin Endocrinol (Oxf) 1990;33:317-21. [PMID: 2253407 DOI: 10.1111/j.1365-2265.1990.tb00496.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 246 |
M Hartwig, I J Körner. Generation of lymphokine-activated killer cells in long-term cultures. Immunology 1990;71. [PMID: 2210801] [Reference Citation Analysis]
|
| 247 |
Hain N, Alsalameh S, Bertling WM, Kalden JR, Burmester GR. Stimulation of rheumatoid synovial and blood T cells and lines by synovial fluid and interleukin-2: characterization of clones and recognition of a co-stimulatory effect. Rheumatol Int 1990;10:203-10. [PMID: 2075373 DOI: 10.1007/BF02274834] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 248 |
Batra J, Fitzgerald D, Gately M, Chaudhary V, Pastan I. Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells. Journal of Biological Chemistry 1990;265:15198-202. [DOI: 10.1016/s0021-9258(18)77241-4] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 249 |
Benjamin D, Rosolen A, Wormsley SB, DeBault LE, Colamonici OR. Expression of low-, intermediate-, and high-affinity IL-2 receptors on B cell lines derived from patients with undifferentiated lymphoma of Burkitt's and non-Burkitt's types. Cell Immunol 1990;129:112-24. [PMID: 2364438 DOI: 10.1016/0008-8749(90)90191-s] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 250 |
N E Kay, J E Morley, J I Allen. Interaction between endogenous opioids and IL-2 on PHA-stimulated human lymphocytes. Immunology 1990;70. [PMID: 2394465] [Reference Citation Analysis]
|
| 251 |
Junghans RP. A strategy for evaluating lymphokine activation and novel monoclonal antibodies in antibody-dependent cell-mediated cytotoxicity and effector cell retargeting assays. Cancer Immunol Immunother 1990;31:207-12. [PMID: 2379218 DOI: 10.1007/BF01789170] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 252 |
Elliott LH, Brooks WH, Roszman TL. Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors. J Clin Invest 1990;86:80-6. [PMID: 2365829 DOI: 10.1172/JCI114719] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 253 |
Imamura M, Fujimoto H, Hashino S, Fukuhara T, Kobayashi M, Kasai M, Sakurada K, Miyazaki T. In vivo administration of cytokine in allogeneic bone marrow chimeras. Immunobiology 1990;180:441-57. [PMID: 1697845 DOI: 10.1016/S0171-2985(11)80305-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 254 |
Sharon M, Gnarra JR, Leonard WJ. A 100-kilodalton protein is associated with the murine interleukin 2 receptor: biochemical evidence that p100 is distinct from the alpha and beta chains. Proc Natl Acad Sci U S A 1990;87:4869-73. [PMID: 2352954 DOI: 10.1073/pnas.87.12.4869] [Cited by in Crossref: 32] [Cited by in F6Publishing: 40] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 255 |
Jafari P, Khansari DN. Detection of somatotropin receptors on human monocytes. Immunol Lett 1990;24:199-202. [PMID: 2384262 DOI: 10.1016/0165-2478(90)90048-u] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 256 |
Penttila IA, Gibson CE, Forrest BD, Cummins AG, LaBrooy JT. Lymphocyte activation as measured by interleukin-2 receptor expression to gluten fraction 111 in coeliac disease. Immunol Cell Biol 1990;68 ( Pt 3):155-60. [PMID: 2228030 DOI: 10.1038/icb.1990.22] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 257 |
Klinger M, Alexiewicz JM, Linker-Israeli M, Pitts TO, Gaciong Z, Fadda GZ, Massry SG. Effect of parathyroid hormone on human T cell activation. Kidney Int 1990;37:1543-51. [PMID: 1972968 DOI: 10.1038/ki.1990.147] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 258 |
Lawrence EC. Diagnosis and Management of Lung Allograft Rejection. Clinics in Chest Medicine 1990;11:269-78. [DOI: 10.1016/s0272-5231(21)00694-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 259 |
Harel-Bellan A, Krief P, Rimsky L, Farrar WL, Mishal Z. Flow cytometry resonance energy transfer suggests an association between low-affinity interleukin 2 binding sites and HLA class I molecules. Biochem J 1990;268:35-40. [PMID: 2111701 DOI: 10.1042/bj2680035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 260 |
Tanaka Y, Shiozawa S, Morimoto I, Fujita T. Role of zinc in interleukin 2 (IL-2)-mediated T-cell activation. Scand J Immunol 1990;31:547-52. [PMID: 2345864 DOI: 10.1111/j.1365-3083.1990.tb02805.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 261 |
Hatamori N, Yokono K, Hayakawa M, Taki T, Ogawa W, Nagata M, Hari J, Shii K, Taniguchi H, Baba S. Anti-interleukin 2 receptor antibody attenuates low-dose streptozotocin-induced diabetes in mice. Diabetologia 1990;33:266-71. [PMID: 2142923 DOI: 10.1007/BF00403319] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 262 |
Schnabl E, Stockinger H, Majdic O, Gaugitsch H, Lindley IJ, Maurer D, Hajek-Rosenmayr A, Knapp W. Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2-microglobulin. J Exp Med 1990;171:1431-42. [PMID: 2139695 DOI: 10.1084/jem.171.5.1431] [Cited by in Crossref: 106] [Cited by in F6Publishing: 116] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 263 |
Jerrells TR, Perritt D, Eckardt MJ, Marietta C. Alterations in interleukin-2 utilization by T-cells from rats treated with an ethanol-containing diet. Alcohol Clin Exp Res 1990;14:245-9. [PMID: 2190491 DOI: 10.1111/j.1530-0277.1990.tb00480.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 264 |
Kono T, Doi T, Yamada G, Hatakeyama M, Minamoto S, Tsudo M, Miyasaka M, Miyata T, Taniguchi T. Murine interleukin 2 receptor beta chain: dysregulated gene expression in lymphoma line EL-4 caused by a promoter insertion. Proc Natl Acad Sci U S A 1990;87:1806-10. [PMID: 2155425 DOI: 10.1073/pnas.87.5.1806] [Cited by in Crossref: 43] [Cited by in F6Publishing: 57] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 265 |
Wang RD, Luo Y, Feng ZH, Chen ZC. Effect of tumor-derived immunosuppressive factor(s) on interleukin 2 and on expression of interleukin 2 receptor. J Tongji Med Univ 1990;10:43-7. [PMID: 2348488 DOI: 10.1007/BF02909121] [Reference Citation Analysis]
|
| 266 |
Stuber G, Vánky F, Pócsik E, Benczúr M, Klein E. Expression of interleukin-2 receptor on blood lymphocytes stimulated with allogeneic lymphocytes or autologous tumor cells. The mixed lymphocyte culture of allo-sensitized individuals and the auto-tumor stimulation show similar kinetics of activation. Cancer Immunol Immunother 1990;31:76-80. [PMID: 2138932 DOI: 10.1007/BF01742369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 267 |
Yagura H, Tamaki T, Furitsu T, Tomiyama Y, Nishiura T, Tominaga N, Katagiri S, Yonezawa T, Tarui S. Demonstration of high-affinity interleukin-2 receptors on B-chronic lymphocytic leukemia cells: functional and structural characterization. Blut 1990;60:181-6. [PMID: 2180499 DOI: 10.1007/BF01720273] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 268 |
Collins MK, Malde P, Miyajima A, Arai K, Smith KA, Mulligan RC. Evidence that the level of the p55 component of the interleukin (IL) 2 receptor can control IL 2 responsiveness in a murine IL 3-dependent cell. Eur J Immunol 1990;20:573-8. [PMID: 2318250 DOI: 10.1002/eji.1830200317] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 269 |
Green JE, Begley CG, Wagner DK, Waldmann TA, Jay G. trans activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene. Mol Cell Biol 1989;9:4731-7. [PMID: 2689863 DOI: 10.1128/mcb.9.11.4731-4737.1989] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 270 |
Campbell S, Kim H, Doukas M, Haley B. Photoaffinity labeling of ATP and NAD+ binding sites on recombinant human interleukin 2. Proc Natl Acad Sci U S A 1990;87:1243-6. [PMID: 2105502 DOI: 10.1073/pnas.87.3.1243] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 271 |
Santoli D, Phillips PD, Colt TL, Zurier RB. Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids. J Clin Invest 1990;85:424-32. [PMID: 2298918 DOI: 10.1172/JCI114455] [Cited by in Crossref: 115] [Cited by in F6Publishing: 122] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 272 |
Fordis CM, Helmly B, Novotny E, Holter W, Barker JL, Howard BH. Transient analysis for antiproliferative gene activity. Proc Natl Acad Sci U S A 1990;87:1169-73. [PMID: 2300576 DOI: 10.1073/pnas.87.3.1169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 273 |
H Takamatsu, T Collen, D L Tucker, M S Denyer. Characterization of long-term cultured bovine CD4-positive and CD8-positive T-cell lines and clones. Immunology 1990;69. [PMID: 1968428] [Reference Citation Analysis]
|
| 274 |
A G Pockley, A E Bolton. The effect of human placental protein 14 (PP14) on the production of interleukin-1 from mitogenically stimulated mononuclear cell cultures. Immunology 1990;69. [PMID: 2307483] [Reference Citation Analysis]
|
| 275 |
Zu Y, Kohno M, Kubota I, Nishida E, Hanaoka M, Namba Y. Characterization of interleukin 2 stimulated 65-kilodalton phosphoprotein in human T cells. Biochemistry 1990;29:1055-62. [PMID: 2111166 DOI: 10.1021/bi00456a030] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 276 |
Allouche M, Georgoulias V, Augery-Bourget Y, Sahraoui Y, Tsapis A, Perraki M, Clemenceau C, Choulakis V, Jasmin C. Phorbol myristate acetate induces both high affinity and low affinity interleukin 2-receptors on a pre-B leukemic cell line. Leuk Res 1990;14:353-61. [PMID: 2332988 DOI: 10.1016/0145-2126(90)90163-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 277 |
Altman A, Coggeshall KM, Mustelin T. Molecular events mediating T cell activation. Adv Immunol 1990;48:227-360. [PMID: 1693465 DOI: 10.1016/s0065-2776(08)60756-7] [Cited by in Crossref: 205] [Cited by in F6Publishing: 233] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 278 |
B M Foxwell, J Simon, J J Herrero, D Taylor, G Woerly, D Cantrell, B Ryffel. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A. Immunology 1990;69. [PMID: 2312149] [Reference Citation Analysis]
|
| 279 |
Saito Y, Honjo T. Why are multiple chains required for the interleukin 2 receptor? Prog Growth Factor Res 1990;2:207-22. [PMID: 2133289 DOI: 10.1016/0955-2235(90)90019-g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 280 |
Vakkila J, Hurme M. Both dendritic cells and monocytes induce autologous and allogeneic T cells receptive to interleukin 2. Scand J Immunol 1990;31:75-83. [PMID: 2137256 DOI: 10.1111/j.1365-3083.1990.tb02745.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 281 |
R Bujdoso, P Young, J Hopkins, I McConnell. IL-2-like activity in lymph fluid following in vivo antigen challenge. Immunology 1990;69. [PMID: 2312156] [Reference Citation Analysis]
|
| 282 |
Stournaras C, Spanakis E, Perraki M, Athanasiou M, Thanos D, Georgoulias V. Triethyllead-induced inhibition of proliferation of normal human lymphocytes through decreased expression of the Tac chain of interleukin 2 receptor. Int J Immunopharmacol 1990;12:349-58. [PMID: 2329022 DOI: 10.1016/0192-0561(90)90092-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 283 |
Choi SJ, Moon YS, Lee BC, Kim DS. Serum levels of soluble interleukin-2 receptor in pulmonary tuberculosis. Korean J Intern Med 1990;5:44-50. [PMID: 2271510 DOI: 10.3904/kjim.1990.5.1.44] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 284 |
Begley CG, Burton JD, Tsudo M, Brownstein BH, Ambrus JL Jr, Waldmann TA. Human B lymphocytes express the p75 component of the interleukin 2 receptor. Leuk Res 1990;14:263-71. [PMID: 2319807 DOI: 10.1016/0145-2126(90)90134-u] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 285 |
Leichtling KD, Serrate SA, Sztein MB. Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes. Int J Immunopharmacol 1990;12:19-29. [PMID: 2303316 DOI: 10.1016/0192-0561(90)90064-t] [Cited by in Crossref: 64] [Cited by in F6Publishing: 70] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 286 |
Ballard DW, Fung MR, Böhnlein E, Greene WC. STRUCTURE OF THE HUMAN INTERLEUKIN 2 RECEPTOR AND THE BIOCHEMICAL BASIS FOR ITS REGULATION. The Molecular Aspects of Autoimmunity 1990. [DOI: 10.1016/b978-0-12-249040-8.50019-5] [Reference Citation Analysis]
|
| 287 |
Allouche M, Sahraoui Y, Augery-Bourget Y, Perrakis M, Jasmin C, Georgoulias V. Interleukin 2 receptors. Leuk Res 1990;14:699-703. [PMID: 2201821 DOI: 10.1016/0145-2126(90)90097-s] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 288 |
Schwinzer B, Resch K. Interleukin 2. In: Habenicht A, editor. Growth Factors, Differentiation Factors, and Cytokines. Berlin: Springer Berlin Heidelberg; 1990. pp. 103-14. [DOI: 10.1007/978-3-642-74856-1_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 289 |
Meroni PL, Barcellini W, Borghi MO, Frasca D, Vismara A, Bamberga P, Ferraro G, Doria G, Zanussi C. Immunopotentiating Activity of Thymopentin Treatment in Elderly Subjects. Biomedical Advances in Aging 1990. [DOI: 10.1007/978-1-4613-0513-2_54] [Reference Citation Analysis]
|
| 290 |
McKeehan WL, Barnes D, Reid L, Stanbridge E, Murakami H, Sato GH. Frontiers in mammalian cell culture. In Vitro Cell Dev Biol 1990;26:9-23. [PMID: 2407711 DOI: 10.1007/BF02624149] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 291 |
Doi T, Hatakeyama M, Minamoto S, Kono T, Mori H, Taniguchi T. Human interleukin 2 (IL 2) receptor beta chain allows transduction of IL 2-induced proliferation signal(s) in a murine cell line. Eur J Immunol 1989;19:2375-8. [PMID: 2606143 DOI: 10.1002/eji.1830191229] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 292 |
Iwai H, Fernandes G. Immunological functions in food-restricted rats: enhanced expression of high-affinity interleukin-2 receptors on splenic T cells. Immunol Lett 1989;23:125-32. [PMID: 2534390 DOI: 10.1016/0165-2478(89)90124-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 293 |
Orson FM, Saadeh CK, Lewis DE, Nelson DL. Interleukin 2 receptor expression by T cells in human aging. Cell Immunol 1989;124:278-91. [PMID: 2510938 DOI: 10.1016/0008-8749(89)90131-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 294 |
Müller C, Knoflach P, Zielinski CC. Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease. Hepatology 1989;10:928-32. [PMID: 2583687 DOI: 10.1002/hep.1840100606] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 295 |
Schmidt C, Burman K, Moss DJ, Ryan J, Burrows SR, Misko IS. Interleukin-2 receptors in infectious mononucleosis. Immunol Lett 1989;23:139-42. [PMID: 2632370 DOI: 10.1016/0165-2478(89)90126-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 296 |
Toribio ML, Gutiérrez-Ramos JC, Pezzi L, Marcos MA, Martínez C. Interleukin-2-dependent autocrine proliferation in T-cell development. Nature 1989;342:82-5. [PMID: 2812004 DOI: 10.1038/342082a0] [Cited by in Crossref: 76] [Cited by in F6Publishing: 81] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 297 |
Lai KN, Leung JC, Lai FM, Tam JS. T-lymphocyte activation in IgA nephropathy: serum-soluble interleukin 2 receptor level, interleukin 2 production, and interleukin 2 receptor expression by cultured lymphocytes. J Clin Immunol 1989;9:485-92. [PMID: 2630571 DOI: 10.1007/BF00918018] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 298 |
Green JE, Begley CG, Wagner DK, Waldmann TA, Jay G. trans activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene. Mol Cell Biol 1989;9:4731-7. [PMID: 2689863 DOI: 10.1128/mcb.9.11.4731-4737.1989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 20] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 299 |
Kawase I, Komuta K, Shirasaka T, Hara H, Tanio Y, Watanabe M, Saito S, Ikeda T, Masuno T, Kishimoto S. Synergy of Nocardia rubra cell wall skeleton and interleukin 2 in the in vivo induction of murine lymphokine-activated killer cell activity. Jpn J Cancer Res 1989;80:1089-97. [PMID: 2514171 DOI: 10.1111/j.1349-7006.1989.tb02264.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 300 |
Saltzman EM, Luhowskyj SM, Casnellie JE. The 75,000-Dalton Interleukin-2 Receptor Transmits a Signal for the Activation of a Tyrosine Protein Kinase. Journal of Biological Chemistry 1989;264:19979-83. [DOI: 10.1016/s0021-9258(19)47207-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 301 |
Zielinski CC, Müller C, Tichatschek E, Aiginger P. Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy. Br J Cancer 1989;60:712-4. [PMID: 2508736 DOI: 10.1038/bjc.1989.345] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 302 |
Blay JY, Bertoglio J, Fradelizi D, Chouaib S. Functional interactions of IL2 and TNF in the differentiation of LGL into LAK effectors. Int J Cancer 1989;44:598-604. [PMID: 2793231 DOI: 10.1002/ijc.2910440407] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 303 |
Beaurain G, Naret C, Marcon L, Grateau G, Drueke T, Urena P, Nelson DL, Bach JF, Chatenoud L. In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients. Kidney Int 1989;36:636-44. [PMID: 2681933 DOI: 10.1038/ki.1989.240] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 304 |
Bujdoso R, Young P, Hopkins J, Allen D, McConnell I. Non-random migration of CD4 and CD8 T cells: changes in the CD4: CD8 ratio and interleukin 2 responsiveness of efferent lymph cells following in vivo antigen challenge. Eur J Immunol 1989;19:1779-84. [PMID: 2511027 DOI: 10.1002/eji.1830191003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 305 |
Chopra RK, Powers DC, Kendig NE, Adler WH, Nagel JE. Soluble interleukin 2 receptors released from mitogen stimulated human peripheral blood lymphocytes bind interleukin 2 and inhibit IL2 dependent cell proliferation. Immunol Invest 1989;18:961-73. [PMID: 2583751 DOI: 10.3109/08820138909045783] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 306 |
Aparicio P, Alonso JM, Toribio ML, Gutierrez JC, Pezzi L, Martínez C. Differential growth requirements and effector functions of alpha/beta and gamma/delta human T cells. Immunol Rev 1989;111:5-33. [PMID: 2697682 DOI: 10.1111/j.1600-065x.1989.tb00540.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 307 |
D C Siess, N S Magnuson, R Reeves. Characterization of the bovine receptor(s) for interleukin-2. Immunology 1989;68. [PMID: 2807377] [Reference Citation Analysis]
|
| 308 |
Ziegler I, Schwuléra U. Modulation of interleukin 2 high-affinity binding by lymphocyte-derived tetrahydrobiopterin: pterins as potential participants in the control of interleukin 2 receptor assembly. J Cell Biochem 1989;41:103-12. [PMID: 2613745 DOI: 10.1002/jcb.240410207] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 309 |
Saito S, Fujii M, Saito M, Kato Y, Moriyama I, Ichijo M. IL-2 receptor expression and function on human cord blood mononuclear cells following PHA and anti-CD3 antibody stimulation. J Reprod Immunol 1989;16:31-42. [PMID: 2532255 DOI: 10.1016/0165-0378(89)90004-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 310 |
Hinuma S, Naruo K, Shiho O, Tsukamoto K. Characteristics of mouse lymphoid cells proliferating in vitro by recombinant human interleukin 2 (TGP-3): comparison between normal and nude mice. Microbiol Immunol 1989;33:761-73. [PMID: 2531267 DOI: 10.1111/j.1348-0421.1989.tb00962.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 311 |
R A van Lier, M Brouwer, V I Rebel, C J van Noesel, L A Aarden. Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes. Immunology 1989;68. [PMID: 2530156] [Reference Citation Analysis]
|
| 312 |
Kradin R, Kurnick J, Gifford J, Pinto C, Preffer F, Lazarus D. Adoptive immunotherapy with interleukin-2 (IL-2) results in diminished IL-2 production by stimulated peripheral blood lymphocytes. J Clin Immunol 1989;9:378-85. [PMID: 2533598 DOI: 10.1007/BF00917102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 313 |
Piao YF, Chiba S, Tojo A, Urabe A, Nara N, Miyazono K, Takaku F. Binding properties and proliferative effects of human recombinant granulocyte-macrophage colony-stimulating factor in primary leukemia and lymphoma. Jpn J Cancer Res 1989;80:887-94. [PMID: 2557316 DOI: 10.1111/j.1349-7006.1989.tb01731.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 314 |
Larsen CS, Christiansen NO. Induction of high-affinity interleukin 2 receptors on human T lymphocytes. The role of calcium and protein kinase C. Scand J Immunol 1989;30:285-94. [PMID: 2506637 DOI: 10.1111/j.1365-3083.1989.tb01213.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 315 |
Foxwell BM, Woerly G, Ryffel B. Identification of interleukin 4 receptor-associated proteins and expression of both high- and low-affinity binding on human lymphoid cells. Eur J Immunol 1989;19:1637-41. [PMID: 2529125 DOI: 10.1002/eji.1830190918] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 316 |
S M Zurawski, G Zurawski. Mouse interleukin-2 structure-function studies: substitutions in the first alpha-helix can specifically inactivate p70 receptor binding and mutations in the fifth alpha-helix can specifically inactivate p55 receptor binding. EMBO J 1989;8. [PMID: 2583124] [Reference Citation Analysis]
|
| 317 |
Taki S, Shimamura T, Abe M, Shirai T, Takahara Y. Biotinylation of human interleukin-2 for flow cytometry analysis of interleukin-2 receptors. J Immunol Methods 1989;122:33-41. [PMID: 2668418 DOI: 10.1016/0022-1759(89)90331-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 318 |
Greene WC, Böhnlein E, Ballard DW. HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises. Immunol Today 1989;10:272-8. [PMID: 2679647 DOI: 10.1016/0167-5699(89)90141-2] [Cited by in Crossref: 86] [Cited by in F6Publishing: 108] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 319 |
Collins MK. Species specificity of interleukin 2 binding to individual receptor components. Eur J Immunol 1989;19:1517-20. [PMID: 2789143 DOI: 10.1002/eji.1830190828] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 320 |
Liang CM, Lee N, Cattell D, Liang SM. Glutathione Regulates Interleukin-2 Activity on Cytotoxic T-cells. Journal of Biological Chemistry 1989;264:13519-23. [DOI: 10.1016/s0021-9258(18)80027-8] [Cited by in Crossref: 90] [Cited by in F6Publishing: 89] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 321 |
A G Pockley, A E Bolton. Placental protein 14 (PP14) inhibits the synthesis of interleukin-2 and the release of soluble interleukin-2 receptors from phytohaemagglutinin-stimulated lymphocytes. Clin Exp Immunol 1989;77. [PMID: 2789118] [Reference Citation Analysis]
|
| 322 |
Takemoto H. Murine interleukin-2 receptor subunits differentially detected with anti-interleukin-2 monoclonal antibodies. FEBS Lett 1989;250:331-5. [PMID: 2787755 DOI: 10.1016/0014-5793(89)80749-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 323 |
Shirasaka T, Kawase I, Okada M, Kitahara M, Ikeda T, Komuta K, Hosoe S, Yokota S, Masuno T, Kishimoto S. Augmentative effect of Nocardia rubra cell-wall skeleton on the induction of human lymphokine-activated killer (LAK) cells by the production of LAK cell helper factor(s). Cancer Immunol Immunother 1989;30:195-204. [PMID: 2598189 DOI: 10.1007/BF01665005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 324 |
T Doi, M Hatakeyama, S Itoh, T Taniguchi. Transient induction of IL-2 receptor in cultured T cell lines by HTLV-1 LTR-linked tax-1 gene. EMBO J 1989;8. [PMID: 2792077] [Reference Citation Analysis]
|
| 325 |
Horuk R, McCubrey JA. The interleukin-1 receptor in Raji human B-lymphoma cells. Molecular characterization and evidence for receptor-mediated activation of gene expression. Biochem J 1989;260:657-63. [PMID: 2527495 DOI: 10.1042/bj2600657] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 326 |
Chaudhary VK, Queen C, Junghans RP, Waldmann TA, FitzGerald DJ, Pastan I. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature 1989;339:394-7. [PMID: 2498664 DOI: 10.1038/339394a0] [Cited by in Crossref: 309] [Cited by in F6Publishing: 324] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 327 |
Tchórzewski H, Luciak M, Trznadel K, Majewska E, Pokoca L. Effect of hemodialysis on T lymphocyte subsets, con-A-activated suppressor cell activity, and interleukin-2 receptor expression on lymphocytes in chronic uremic patients. Artif Organs 1989;13:185-9. [PMID: 2527490 DOI: 10.1111/j.1525-1594.1989.tb02861.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 328 |
Benjamin D, Hartmann DP, Bazar LS, Jacobson RJ, Gilmore MS. Human B cell lines can be triggered to secrete an interleukin 2-like molecule. Cell Immunol 1989;121:30-48. [PMID: 2785866 DOI: 10.1016/0008-8749(89)90003-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 329 |
Hovdenes J, Gaudernack G, Kvien TK, Egeland T. Expression of activation markers on CD4+ and CD8+ cells from synovial fluid, synovial tissue, and peripheral blood of patients with inflammatory arthritides. Scand J Immunol 1989;29:631-9. [PMID: 2544985 DOI: 10.1111/j.1365-3083.1989.tb01167.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 330 |
Laurence J, Friedman SM, Chartash EK, Crow MK, Posnett DN. Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion. J Clin Invest 1989;83:1843-8. [PMID: 2470786 DOI: 10.1172/JCI114090] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 331 |
Schibeci S, Hersey P, Cheresh D. Potentiation of interleukin-2 production and its binding by monoclonal antibodies to the gangliosides GD3 and GD2. Cancer Immunol Immunother 1989;29:109-17. [PMID: 2524255 DOI: 10.1007/BF00199285] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 332 |
Yamaue H, Tanimura H, Iwahashi M, Tani M, Tsunoda T, Tabuse K, Kuribayashi K, Saito K. Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432. Cancer Immunol Immunother 1989;29:79-86. [PMID: 2497980 DOI: 10.1007/BF00199281] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 333 |
Horuk R. A rapid and direct method for the detection and quantification of interleukin-1 receptors using 96 well filtration plates. J Immunol Methods 1989;119:255-8. [PMID: 2524531 DOI: 10.1016/0022-1759(89)90404-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 334 |
Cossarizza A, Monti D, Bersani F, Paganelli R, Montagnani G, Cadossi R, Cantini M, Franceschi C. Extremely low frequency pulsed electromagnetic fields increase interleukin-2 (IL-2) utilization and IL-2 receptor expression in mitogen-stimulated human lymphocytes from old subjects. FEBS Lett 1989;248:141-4. [PMID: 2785933 DOI: 10.1016/0014-5793(89)80449-1] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 335 |
Böhnlein E, Ballard DW, Bogerd H, Peffer NJ, Lowenthal JW, Greene WC. Induction of Interleukin-2 Receptor-α Gene Expression Is Regulated by Post-translational Activation of κ B Specific DNA Binding Proteins. Journal of Biological Chemistry 1989;264:8475-8. [DOI: 10.1016/s0021-9258(18)81813-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 336 |
Teodorczyk-Injeyan JA, Sparkes BG, Mills GB, Falk RE, Peters WJ. Increase of serum interleukin 2 receptor level in thermally injured patients. Clin Immunol Immunopathol 1989;51:205-15. [PMID: 2784753 DOI: 10.1016/0090-1229(89)90020-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 337 |
Magrin S, Craxì A, Carini C, Colombo P, di Blasi F, Spinelli G, Fratazzi C, Messina MC, Antonelli G, Ausiello C. Interleukin-2, interleukin-2 receptor and gamma-interferon synthesis by peripheral blood mononuclear cells in chronic hepatitis delta virus infection. J Hepatol 1989;8:358-66. [PMID: 2499617 DOI: 10.1016/0168-8278(89)90035-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 338 |
Tanaka T, Saiki O, Negoro S, Igarashi T, Kuritani T, Hara H, Suemura M, Kishimoto S. Decreased expression of interleukin-2 binding molecules (p70/75) in T cells from patients with systemic lupus erythematosus. Arthritis Rheum 1989;32:552-9. [PMID: 2785798 DOI: 10.1002/anr.1780320507] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 339 |
Sekigawa I, Noguchi K, Hasegawa K, Hirose S, Sato H, Shirai T. B cell hyperresponsiveness to interleukin 2 and the age-associated decline in murine lupus. Clin Immunol Immunopathol 1989;51:172-84. [PMID: 2784751 DOI: 10.1016/0090-1229(89)90017-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 340 |
Padrós MR, Salamone MC, Zunszain PA, Fainboim L. Differential expression of CD25 and HC2 antigens on subtypes of acute myeloid leukemias. Eur J Haematol 1989;42:436-40. [PMID: 2659380 DOI: 10.1111/j.1600-0609.1989.tb01467.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 341 |
Harel-Bellan A, Mishal Z, Willette-Brown J, Farrar WL. Detection of low and high affinity binding sites with fluoresceinated human recombinant interleukin-2. J Immunol Methods 1989;119:127-33. [PMID: 2496169 DOI: 10.1016/0022-1759(89)90389-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 342 |
R Bujdoso, P Young, G D Harkiss, I McConnell. Antigen presentation in the sheep: generation of antigen-specific T-cell lines. Immunology 1989;66. [PMID: 2469643] [Reference Citation Analysis]
|
| 343 |
Coquerelle TM, Eichhorn M, Magnuson NS, Reeves R, Williams RO, Dobbelaere DA. Expression and characterization of the interleukin 2 receptor in Theileria parva-infected bovine lymphocytes. Eur J Immunol 1989;19:655-9. [PMID: 2786471 DOI: 10.1002/eji.1830190413] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 344 |
Strom TB, Kelley VE. Toward more selective therapies to block undesired immune responses. Kidney Int 1989;35:1026-33. [PMID: 2651766 DOI: 10.1038/ki.1989.86] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 345 |
Weigel U, Meyer M, Sebald W. Mutant proteins of human interleukin 2. Renaturation yield, proliferative activity and receptor binding. Eur J Biochem 1989;180:295-300. [PMID: 2647490 DOI: 10.1111/j.1432-1033.1989.tb14647.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 346 |
Mendelsohn CL, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989;56:855-65. [PMID: 2538245 DOI: 10.1016/0092-8674(89)90690-9] [Cited by in Crossref: 825] [Cited by in F6Publishing: 865] [Article Influence: 24.3] [Reference Citation Analysis]
|
| 347 |
Linsley PS, Bolton-hanson M, Horn D, Malik N, Kallestad JC, Ochs V, Zarling JM, Shoyab M. Identification and characterization of cellular receptors for the growth regulator, oncostatin M. Journal of Biological Chemistry 1989;264:4282-9. [DOI: 10.1016/s0021-9258(18)83737-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 348 |
Kanamori H, Suzuki N, Ishida N, Honjo T. Transcriptional regulation alone does not explain the constitutive expression of the interleukin 2 receptor (Tac/L-chain) in HTLV-1 infected cells. Immunol Lett 1989;20:293-8. [PMID: 2469652 DOI: 10.1016/0165-2478(89)90037-0] [Reference Citation Analysis]
|
| 349 |
Schwartz D, Wong RC, Chatila T, Arnaout A, Miller R, Geha R. Proliferation of highly purified T cells in response to signaling via surface receptors requires cell-cell contact. J Clin Immunol 1989;9:151-8. [PMID: 2654172 DOI: 10.1007/BF00916943] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 350 |
Legraverend C, Potter A, Hölttä E, Alitalo K, Andersson LC. Interleukin-2 induces a rapid increase in ornithine decarboxylase mRNA in a cloned murine T lymphocytic cell line. Exp Cell Res 1989;181:273-81. [PMID: 2645150 DOI: 10.1016/0014-4827(89)90201-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 351 |
Kozarsky KF, Call SM, Dower SK, Krieger M. Abnormal intracellular sorting of O-linked carbohydrate-deficient interleukin-2 receptors. Mol Cell Biol 1988;8:3357-63. [PMID: 3264879 DOI: 10.1128/mcb.8.8.3357-3363.1988] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 352 |
Nakajima M, Yamamoto M, Ushikubi F, Okuma M, Fujiwara M, Narumiya S. Expression of thromboxane A2 receptor in cultured human erythroleukemia cells and its induction by 12-O-tetradecanoylphorbol-13-acetate. Biochem Biophys Res Commun 1989;158:958-65. [PMID: 2522003 DOI: 10.1016/0006-291x(89)92815-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 353 |
Tigges MA, Casey LS, Koshland ME. Mechanism of interleukin-2 signaling: mediation of different outcomes by a single receptor and transduction pathway. Science 1989;243:781-6. [PMID: 2492678 DOI: 10.1126/science.2492678] [Cited by in Crossref: 113] [Cited by in F6Publishing: 123] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 354 |
Osawa H, Diamantstein T. Studies on the formation of high-affinity IL-2 binding sites of an IL-2 receptor p55 + p75 heterodimeric complex: functional importance of a determinant on the p55 subunit defined by a monoclonal antibody AHT-107. Immunol Lett 1989;20:205-12. [PMID: 2469650 DOI: 10.1016/0165-2478(89)90081-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 355 |
Jothy S, Abadie A, Froussard P, Duphot M, Thèze J. Transient nuclear location of the IL-2 receptor during T cell activation. Exp Mol Pathol 1989;50:84-91. [PMID: 2522058 DOI: 10.1016/0014-4800(89)90058-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 356 |
Giannella G, Pelosi-Testa E, Carlini P, Habetswallner D, Montesoro E, Camagna A, Calzini V, Ruggeri EM, Arena MG, Masciulli R. Fluctuations of plasma beta 2-microglobulin, soluble interleukin 2 receptor and interferon-gamma concentrations after adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells. Immunobiology 1989;178:305-15. [PMID: 2497064 DOI: 10.1016/s0171-2985(89)80054-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 357 |
T Sakane, S Takada. Possible involvement of the CD4 molecule in a late activation event on CD4+ T cell proliferation in the human autologous mixed lymphocyte reaction. Clin Exp Immunol 1989;75. [PMID: 2522840] [Reference Citation Analysis]
|
| 358 |
Nakamura Y, Inamoto T, Sugie K, Masutani H, Shindo T, Tagaya Y, Yamauchi A, Ozawa K, Yodoi J. Mitogenicity and down-regulation of high-affinity interleukin 2 receptor by YTA-1 and YTA-2, monoclonal antibodies that recognize 75-kDa molecules on human large granular lymphocytes. Proc Natl Acad Sci U S A 1989;86:1318-22. [PMID: 2465549 DOI: 10.1073/pnas.86.4.1318] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 359 |
Fernandez-Botran R, Sanders VM, Vitetta ES. Interactions between receptors for interleukin 2 and interleukin 4 on lines of helper T cells (HT-2) and B lymphoma cells (BCL1). J Exp Med 1989;169:379-91. [PMID: 2521354 DOI: 10.1084/jem.169.2.379] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 360 |
Toossi Z, Paris MR, Purvis SF, Ellner JJ. Regulation of human T-cell production of interleukin 2 by Leu 11 (CD16) positive large granular lymphocytes. Cell Immunol 1989;118:413-24. [PMID: 2521310 DOI: 10.1016/0008-8749(89)90389-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 361 |
Minamoto S, Itoh S, Kono T, Doi T, Hatakeyama M. Ligand-dependent selection of the receptor gene: segregation of IL-2 binding activity and anti-Tac reactivity by a single amino acid alteration in the Tac antigen (p55). Immunol Lett 1989;20:139-47. [PMID: 2785497 DOI: 10.1016/0165-2478(89)90099-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 362 |
Fong TC, Makinodan T. Preferential enhancement by 2-mercaptoethanol of IL-2 responsiveness of T blast cells from old over young mice is associated with potentiated protein kinase C translocation. Immunol Lett 1989;20:149-54. [PMID: 2785498 DOI: 10.1016/0165-2478(89)90100-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 363 |
Sileghem M, Darji A, Remels L, Hamers R, De Baetselier P. Different mechanisms account for the suppression of interleukin 2 production and the suppression of interleukin 2 receptor expression in Trypanosoma brucei-infected mice. Eur J Immunol 1989;19:119-24. [PMID: 2563971 DOI: 10.1002/eji.1830190119] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 364 |
Sands H, Loveless SE. Biodistribution and pharmacokinetics of recombinant, human 125I-interleukin-2 in mice. Int J Immunopharmacol 1989;11:411-6. [PMID: 2789199 DOI: 10.1016/0192-0561(89)90088-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 365 |
Robb RJ. Structure-function relationships for high and low-affinity interleukin 2 receptors. Adv Exp Med Biol 1989;254:61-5. [PMID: 2683608 DOI: 10.1007/978-1-4757-5803-0_8] [Reference Citation Analysis]
|
| 366 |
Crosier PS, Skinner M, Le Gros G, Holdaway K, Watson JD. Growth of fetal thymocytes in organ culture: effect of recombinant lymphokines on thymocyte maturation. Growth Factors 1989;1:299-310. [PMID: 2483921 DOI: 10.3109/08977198909000254] [Reference Citation Analysis]
|
| 367 |
Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 1989;44:153-205. [PMID: 2466396 DOI: 10.1016/s0065-2776(08)60642-2] [Cited by in Crossref: 852] [Cited by in F6Publishing: 902] [Article Influence: 25.1] [Reference Citation Analysis]
|
| 368 |
Vitetta ES, Fernandez-Botran R, Myers CD, Sanders VM. Cellular interactions in the humoral immune response. Adv Immunol 1989;45:1-105. [PMID: 2665437 DOI: 10.1016/s0065-2776(08)60692-6] [Cited by in Crossref: 89] [Cited by in F6Publishing: 96] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 369 |
Diamantstein T, Volk H, Hahn HJ, Tilney NL, Kupiec-weglinski JW. Interleukin 2 Receptor Targeted Immunotherapy — Update and Attempt at Synthesis. In: Melchers F, Albert ED, von Boehmer H, Dierich MP, Du Pasquier L, Eichmann K, Gemsa D, Götze O, Kalden JR, Kaufmann SHE, Kirchner H, Resch K, Riethmüller G, Schimpl A, Sorg C, Steinmetz M, Wagner H, Zachau HG, editors. Progress in Immunology. Berlin: Springer Berlin Heidelberg; 1989. pp. 619-26. [DOI: 10.1007/978-3-642-83755-5_83] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 370 |
Waldmann TA, Goldman C, Tsudo M. The Multichain Interleukin-2 Receptor: From the Gene to the Bedside. Clinical Chemistry 1989. [DOI: 10.1007/978-1-4613-0753-2_68] [Reference Citation Analysis]
|
| 371 |
Gardner P, Alcover A, Kuno M, Moingeon P, Weyand CM, Goronzy J, Reinherz EL. Triggering of T-lymphocytes via Either T3-Ti or T11 Surface Structures Opens a Voltage-insensitive Plasma Membrane Calcium-permeable Channel: Requirement for Interleukin-2 Gene Function. Journal of Biological Chemistry 1989;264:1068-76. [DOI: 10.1016/s0021-9258(19)85055-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 372 |
Waldmann TA. Disorders of IL-2 Receptor Expression in HTLV-IAssociated Adult T Cell Leukemia. Retroviruses and Disease 1989. [DOI: 10.1016/b978-0-12-322570-2.50011-5] [Reference Citation Analysis]
|
| 373 |
Williams DP, Bacha P, Kelley V, Strom TB, Murphy JR. Adenosine Diphosphate Ribosylation of Elongation Factor-2 as a Therapeutic Target: Genetic Construction and Selective Action of a Diphtheria Toxin-Related Interleukin-2 Fusion Protein. ADP-Ribose Transfer Reactions 1989. [DOI: 10.1007/978-1-4615-8507-7_89] [Reference Citation Analysis]
|
| 374 |
Hatamori N, Yokono K, Nagata M, Doi K, Baba S. Interleukin 2/interleukin 2 receptor system in type 1 diabetes. Diabetes Res Clin Pract 1989;7 Suppl 1:S67-72. [PMID: 2680368 DOI: 10.1016/0168-8227(89)90090-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 375 |
Takemoto H, Murai Y, Ide M. Monoclonal antibodies which differentiate high- and low-affinity binding sites of interleukin-2. FEBS Lett 1988;242:53-6. [PMID: 3264537 DOI: 10.1016/0014-5793(88)80983-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 376 |
Lorberboum-galski H, Kozak RW, Waldmann TA, Bailon P, Fitzgerald DJ, Pastan I. Interleukin 2 (IL2) PE40 is cytotoxic to cells displaying either the p55 or p70 subunit of the IL2 receptor. Journal of Biological Chemistry 1988;263:18650-6. [DOI: 10.1016/s0021-9258(18)37334-4] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 377 |
Agostini C, Poletti V, Zambello R, Trentin L, Siviero F, Spiga L, Gritti F, Semenzato G. Phenotypical and functional analysis of bronchoalveolar lavage lymphocytes in patients with HIV infection. Am Rev Respir Dis 1988;138:1609-15. [PMID: 3202512 DOI: 10.1164/ajrccm/138.6.1609] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 378 |
Herrmann T, Diamantstein T. The high affinity interleukin 2 receptor: evidence for three distinct polypeptide chains comprising the high affinity interleukin 2 receptor. Mol Immunol 1988;25:1201-7. [PMID: 3265478 DOI: 10.1016/0161-5890(88)90156-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 379 |
Saito Y, Sabe H, Suzuki N, Kondo S, Ogura T, Shimizu A, Honjo T. A larger number of L chains (Tac) enhance the association rate of interleukin 2 to the high affinity site of the interleukin 2 receptor. J Exp Med 1988;168:1563-72. [PMID: 3263463 DOI: 10.1084/jem.168.5.1563] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 380 |
Fung MR, Ju G, Greene WC. Co-internalization of the p55 and p70 subunits of the high-affinity human interleukin 2 receptor. Evidence for a stable ternary receptor complex. J Exp Med 1988;168:1923-8. [PMID: 3263468 DOI: 10.1084/jem.168.5.1923] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 381 |
Semenzato G, Bambara LM, Biasi D, Frigo A, Vinante F, Zuppini B, Trentin L, Feruglio C, Chilosi M, Pizzolo G. Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol 1988;8:447-52. [PMID: 3065351 DOI: 10.1007/BF00916949] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 382 |
Kumagai N, Benedict SH, Mills GB, Gelfand EW. Induction of competence and progression signals in human T lymphocytes by phorbol esters and calcium ionophores. J Cell Physiol 1988;137:329-36. [PMID: 3263971 DOI: 10.1002/jcp.1041370217] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 383 |
Trón L, Aszalós A, Balázs M, Mulhern SA, Szöllösi J, Damjanovich S. On the biophysics of transmembrane signalling. Mol Immunol 1988;25:1075-80. [PMID: 3065628 DOI: 10.1016/0161-5890(88)90140-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 384 |
Lindqvist C, Mogensen EL, Koman A. Improved method for multisample evaluation of ligand binding to cells. Application to IL-2 receptor measurement. J Immunol Methods 1988;113:231-5. [PMID: 3262689 DOI: 10.1016/0022-1759(88)90336-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 385 |
Foxwell BM, Taylor D, Greiner B, Mihatsch MJ, Olivieri V, Ryffel B. Biotinylated recombinant interleukin-2. A tool for research on the interleukin-2 receptor. J Immunol Methods 1988;113:221-9. [PMID: 3262688 DOI: 10.1016/0022-1759(88)90335-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 386 |
Collins L, Tsien WH, Seals C, Hakimi J, Weber D, Bailon P, Hoskings J, Greene WC, Toome V, Ju G. Identification of specific residues of human interleukin 2 that affect binding to the 70-kDa subunit (p70) of the interleukin 2 receptor. Proc Natl Acad Sci U S A 1988;85:7709-13. [PMID: 3051003 DOI: 10.1073/pnas.85.20.7709] [Cited by in Crossref: 68] [Cited by in F6Publishing: 76] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 387 |
Foxwell B, Taylor D, Ryffel B. Comparison of the structure of the murine interleukin 2 (IL 2) receptor on cytotoxic and helper T cell lines by chemical cross-linking of 125I-labeled IL 2. Eur J Immunol 1988;18:1515-9. [PMID: 2973414 DOI: 10.1002/eji.1830181007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 388 |
Osheroff PL, Gately MK, Skaleris DA, Wilson DE, Seals CM, Hakimi J, Tsien WH. Human interleukin-2 anti-idiotypes. Hybridoma 1988;7:417-27. [PMID: 3264260 DOI: 10.1089/hyb.1988.7.417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 389 |
Konishi K, Moller DR, Saltini C, Kirby M, Crystal RG. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis. J Clin Invest 1988;82:775-81. [PMID: 3138285 DOI: 10.1172/JCI113678] [Cited by in Crossref: 49] [Cited by in F6Publishing: 59] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 390 |
Bloemena E, van Oers MH, Weinreich S, Yong SL, Schellekens PT. Prednisolone and cyclosporin A exert differential inhibitory effects on T-cell proliferation in vitro. Clin Immunol Immunopathol 1988;48:380-91. [PMID: 3261215 DOI: 10.1016/0090-1229(88)90032-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 391 |
Mita S, Harada N, Naomi S, Hitoshi Y, Sakamoto K, Akagi M, Tominaga A, Takatsu K. Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication. J Exp Med 1988;168:863-78. [PMID: 3262707 DOI: 10.1084/jem.168.3.863] [Cited by in Crossref: 60] [Cited by in F6Publishing: 73] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 392 |
Schwab R, Weksler ME, Russo C. CD3 pathway of T-cell activation. II. Role of HLA-class I molecules in early events. Cell Immunol 1988;115:310-24. [PMID: 2457448 DOI: 10.1016/0008-8749(88)90184-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 393 |
Emery P, Wood N, Gentry K, Stockman A, Mackay IR, Bernard O. High-affinity interleukin-2 receptors on blood lymphocytes are decreased during active rheumatoid arthritis. Arthritis Rheum 1988;31:1176-81. [PMID: 3139003 DOI: 10.1002/art.1780310914] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 394 |
Fujii M, Sugamura K, Nakamura M, Ishii T, Hinuma Y. Selective inhibition of high- but not low-affinity interleukin 2 binding by lectins and anti-interleukin 2 receptor alpha antibody. Microbiol Immunol 1988;32:857-67. [PMID: 3143899 DOI: 10.1111/j.1348-0421.1988.tb01447.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 395 |
Hatakeyama M, Taniguchi T. Dysregulation of growth factor-receptor system in cellular transformation. Jpn J Cancer Res 1988;79:885-901. [PMID: 3141325 DOI: 10.1111/j.1349-7006.1988.tb00052.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 396 |
Robb RJ, Rusk CM, Neeper MP. Structure-function relationships for the interleukin 2 receptor: location of ligand and antibody binding sites on the Tac receptor chain by mutational analysis. Proc Natl Acad Sci U S A 1988;85:5654-8. [PMID: 3135551 DOI: 10.1073/pnas.85.15.5654] [Cited by in Crossref: 39] [Cited by in F6Publishing: 48] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 397 |
Watson JD, Leung E, Eszes M, Le Gros GS, Prestidge RL, Booth RJ, Overell RA, Gillis S. Expression of functional human interleukin-2 receptors in murine interleukin-3-dependent cells. Immunol Cell Biol 1988;66 ( Pt 4):319-30. [PMID: 3154924 DOI: 10.1038/icb.1988.42] [Reference Citation Analysis]
|
| 398 |
Chin J, Rupp E, Cameron PM, MacNaul KL, Lotke PA, Tocci MJ, Schmidt JA, Bayne EK. Identification of a high-affinity receptor for interleukin 1 alpha and interleukin 1 beta on cultured human rheumatoid synovial cells. J Clin Invest 1988;82:420-6. [PMID: 2969918 DOI: 10.1172/JCI113614] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 399 |
M Linker-Israeli, J D Gray, F P Quismorio, D A Horwitz. Characterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosus. Clin Exp Immunol 1988;73. [PMID: 2972425] [Reference Citation Analysis]
|
| 400 |
Kan M, Disorbo D, Hou JZ, Hoshi H, Mansson PE, Mckeehan WL. High and low affinity binding of heparin-binding growth factor to a 130-kDa receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma cell. Journal of Biological Chemistry 1988;263:11306-13. [DOI: 10.1016/s0021-9258(18)37959-6] [Cited by in Crossref: 83] [Cited by in F6Publishing: 53] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 401 |
Kozarsky KF, Call SM, Dower SK, Krieger M. Abnormal intracellular sorting of O-linked carbohydrate-deficient interleukin-2 receptors. Mol Cell Biol 1988;8:3357-63. [PMID: 3264879 DOI: 10.1128/mcb.8.8.3357-3363.1988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 402 |
Barcellini W, Meroni PL, Borghi MO, Frasca D, Perego R, Doria G, Zanussi C. In vivo immunopotentiating activity of thymopentin in aging humans: modulation of IL-2 receptor expression. Clin Immunol Immunopathol 1988;48:140-9. [PMID: 3134150 DOI: 10.1016/0090-1229(88)90078-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 403 |
Larsen CS, Christiansen NO, Esmann V. Modulation of high-affinity interleukin 2 receptors on activated human T lymphocytes by activators of protein kinase C. Scand J Immunol 1988;28:167-75. [PMID: 3137654 DOI: 10.1111/j.1365-3083.1988.tb02428.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 404 |
Keystone EC, Snow KM, Bombardier C, Chang CH, Nelson DL, Rubin LA. Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum 1988;31:844-9. [PMID: 3134896 DOI: 10.1002/art.1780310704] [Cited by in Crossref: 90] [Cited by in F6Publishing: 97] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 405 |
Jacques Y, Paineau J, Chevalier S, Le Mauff B, Soulillou JP. A study on OX39, a murine anti-rat interleukin 2 receptor antibody. A report on receptor binding and effects on allograft survival. Transpl Int 1988;1:58-63. [PMID: 3076381 DOI: 10.1007/BF00353820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 406 |
Herrmann T, Diamantstein T. The human intermediate-affinity interleukin 2 receptor consists of two distinct, partially homologous glycoproteins. Eur J Immunol 1988;18:1051-7. [PMID: 3136023 DOI: 10.1002/eji.1830180713] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 407 |
Böhnlein E, Lowenthal JW, Siekevitz M, Ballard DW, Franza BR, Greene WC. The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell 1988;53:827-36. [PMID: 2836068 DOI: 10.1016/0092-8674(88)90099-2] [Cited by in Crossref: 293] [Cited by in F6Publishing: 364] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 408 |
E Pelosi-Testa, P Samoggia, G Giannella, E Montesoro, T Caravita, G Salvo, A Camagna, G Isacchi, U Testa, C Peschle. Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level. Immunology 1988;64. [PMID: 3134296] [Reference Citation Analysis]
|
| 409 |
Gaulton GN, Markmann JF. Regulation of lymphocyte growth by antagonists of interleukin-2 or its cellular receptor. Immunol Res 1988;7:113-35. [PMID: 3134498 DOI: 10.1007/BF02918096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 410 |
Thompson LP, Di Sabato G. Purification and characterization of two forms of rat interleukin-2. Cell Immunol 1988;114:12-26. [PMID: 2967110 DOI: 10.1016/0008-8749(88)90251-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 411 |
Beckers T, Hauser HJ, Hüsken D, Engels JW. Expression and characterization of a des-methionine mutant interleukin-2 receptor (Tac protein) with interleukin-2 binding affinity. Journal of Biological Chemistry 1988;263:8359-65. [DOI: 10.1016/s0021-9258(18)68485-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 412 |
Honda M, Nagao S, Yamamoto N, Tanaka Y, Tozawa H, Tokunaga T. Fluorescence sandwich enzyme-linked immunosorbent assay for detecting human interleukin-2 receptors. J Immunol Methods 1988;110:129-36. [PMID: 2453583 DOI: 10.1016/0022-1759(88)90092-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 413 |
Barcellini W, Borghi MO, Sguotti C, Palmieri R, Frasca D, Meroni PL, Doria G, Zanussi C. Heterogeneity of immune responsiveness in healthy elderly subjects. Clin Immunol Immunopathol 1988;47:142-51. [PMID: 3127098 DOI: 10.1016/0090-1229(88)90067-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 414 |
Jothy S, Abadie A, Froussard P, Duphot M, Thèze J. Nuclear location of the p55 subunit of the IL-2 receptor following activation of the HT-2 T helper cell line. Ann Inst Pasteur Immunol 1988;139:237-44. [PMID: 2971378 DOI: 10.1016/0769-2625(88)90137-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 415 |
Caspi RR, McAllister CG, Gery I, Nussenblatt RB. Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis. Cell Immunol 1988;113:350-60. [PMID: 2965988 DOI: 10.1016/0008-8749(88)90033-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 416 |
Plum J, De Smedt M. Differentiation of thymocytes in fetal organ culture: lack of evidence for the functional role of the interleukin 2 receptor expressed by prothymocytes. Eur J Immunol 1988;18:795-9. [PMID: 3132397 DOI: 10.1002/eji.1830180521] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 417 |
Saltzman EM, Thom RR, Casnellie JE. Activation of a tyrosine protein kinase is an early event in the stimulation of T lymphocytes by interleukin-2. Journal of Biological Chemistry 1988;263:6956-9. [DOI: 10.1016/s0021-9258(18)68588-6] [Cited by in Crossref: 101] [Cited by in F6Publishing: 75] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 418 |
Naeim F. Hairy cell leukemia: characteristics of the neoplastic cells. Hum Pathol 1988;19:375-88. [PMID: 3284803 DOI: 10.1016/s0046-8177(88)80485-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 419 |
Liang SM, Lee N, Zoon KC, Manischewitz JF, Chollet A, Liang CM, Quinnan GV. Biological characterization of human interleukin-2 mutant proteins. Structure-activity relationship studies. Journal of Biological Chemistry 1988;263:4768-72. [DOI: 10.1016/s0021-9258(18)68851-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 420 |
Bowlin TL, Bitonti AJ, McKown BJ. Decreased interleukin-2 responsiveness in leukocytes from Trypanosoma brucei-infected mice. Cell Immunol 1988;112:437-41. [PMID: 3128404 DOI: 10.1016/0008-8749(88)90313-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 421 |
A D Weinberg, J Shaw, V Paetkau, R C Bleackley, N S Magnuson, R Reeves, J A Magnuson. Cloning of cDNA for the bovine IL-2 receptor (bovine Tac antigen). Immunology 1988;63. [PMID: 2835311] [Reference Citation Analysis]
|
| 422 |
Sharon M, Siegel JP, Tosato G, Yodoi J, Gerrard TL, Leonard WJ. The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells. J Exp Med 1988;167:1265-70. [PMID: 2832509 DOI: 10.1084/jem.167.3.1265] [Cited by in Crossref: 41] [Cited by in F6Publishing: 57] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 423 |
Sia DY, Chou JL. Analysis of human peripheral blood T lymphocytes proliferating in response to sensitizing antigens: effect of interleukin-2 (IL-2)-responsive bystander cells. Immunol Invest 1988;17:77-83. [PMID: 3134300 DOI: 10.3109/08820138809055720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 424 |
Zeitz M, Greene WC, Peffer NJ, James SP. Lymphocytes isolated from the intestinal lamina propria of normal nonhuman primates have increased expression of genes associated with T-cell activation. Gastroenterology 1988;94:647-55. [PMID: 3123303 DOI: 10.1016/0016-5085(88)90235-1] [Cited by in Crossref: 127] [Cited by in F6Publishing: 131] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 425 |
Prince HE, Kleinman SH, Maino VC, Jackson AL. In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis. J Clin Immunol 1988;8:114-20. [PMID: 2967306 DOI: 10.1007/BF00917899] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 426 |
Numazaki K, Goldman H, Wainberg MA. Effect of co-incubation with cytomegalovirus on growth of interleukin 2-dependent lymphocytes. Microb Pathog 1988;4:137-44. [PMID: 2462156 DOI: 10.1016/0882-4010(88)90055-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 427 |
Bacha P, Williams DP, Waters C, Williams JM, Murphy JR, Strom TB. Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein. J Exp Med 1988;167:612-22. [PMID: 3126255 DOI: 10.1084/jem.167.2.612] [Cited by in Crossref: 183] [Cited by in F6Publishing: 193] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 428 |
Hoon DS, Irie RF, Cochran AJ. Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2. Cell Immunol 1988;111:410-9. [PMID: 3123073 DOI: 10.1016/0008-8749(88)90104-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 429 |
E Bloemena, M H Van Oers, S Weinreich, P T Schellekens. Cyclosporin A and prednisolone do not inhibit the expression of high-affinity receptors for interleukin 2. Clin Exp Immunol 1988;71. [PMID: 2832109] [Reference Citation Analysis]
|
| 430 |
Sia DY. Differential regulation of interleukin 2 (IL-2) receptor expression on antigen-specific human T cell clones by IL-2. Immunol Lett 1988;17:13-9. [PMID: 2450841 DOI: 10.1016/0165-2478(88)90095-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 431 |
Murphy JR, Williams DP, Bacha P, Bishai W, Waters C, Strom TB. Cell receptor specific targeted toxins: genetic construction and characterization of an interleukin 2 diphtheria toxin-related fusion protein. J Recept Res 1988;8:467-80. [PMID: 3133472 DOI: 10.3109/10799898809049005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 432 |
Lotze MT, Rosenberg SA. INTERLEUKIN 2 AS A PHARMACOLOGIC REAGENT. Interleukin. Elsevier; 1988. pp. 237-94. [DOI: 10.1016/b978-0-12-651420-9.50017-8] [Cited by in Crossref: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 433 |
Froelich CJ, Burkett JS, Guiffaut S, Kingsland R, Brauner D. Phytohemagglutinin induced proliferation by aged lymphocytes: reduced expression of high affinity interleukin-2 receptors and interleukin-2 secretion. Life Sci 1988;43:1583-90. [PMID: 3264041 DOI: 10.1016/0024-3205(88)90529-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 434 |
Di Giovine FS, Symons JA, Manson J, Duff GW. Soluble mediators of immunity: interleukins. Immunopathogenetic Mechanisms of Arthritis 1988. [DOI: 10.1007/978-94-009-1293-9_6] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 435 |
Greene WC. The Molecular Biology of the Human Interleukin-2 Receptor. Cellular and Molecular Aspects of Inflammation 1988. [DOI: 10.1007/978-1-4684-5487-1_19] [Reference Citation Analysis]
|
| 436 |
Owen-Schaub LB, Loudon WG, Yagita M, Grimm EA. Functional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptors. Cell Immunol 1988;111:235-46. [PMID: 3123071 DOI: 10.1016/0008-8749(88)90066-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 437 |
Kehrl JH, Dukovich M, Whalen G, Katz P, Fauci AS, Greene WC. Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells. J Clin Invest 1988;81:200-5. [PMID: 2826541 DOI: 10.1172/JCI113295] [Cited by in Crossref: 52] [Cited by in F6Publishing: 64] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 438 |
Mills GB, Benedict S, Gelfand EW, Mellors A, Grinstein S. TRANSMEMBRANE SIGNALING BY INTERLEUKIN 2. Interleukin. Elsevier; 1988. pp. 113-35. [DOI: 10.1016/b978-0-12-651420-9.50011-7] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 439 |
Robb RJ. Structure—Function Relations for the Interleukin-2 Receptor. Cellular and Molecular Aspects of Inflammation 1988. [DOI: 10.1007/978-1-4684-5487-1_7] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 440 |
Cox GW, Orosz CG, Lewis MG, Olsen RG, Fertel RH. Evidence that 8-methoxypsoralen (8-MOP) is a T-lymphocyte immunomodulatory agent. Int J Immunopharmacol 1988;10:773-81. [PMID: 3264275 DOI: 10.1016/0192-0561(88)90031-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 441 |
Schrader J, Clark-lewis I, Crapper R, Leslie K, Schrader S, Varigos G, Ziltener H. The Panspecific Hemopoietin Interleukin 3: Physiology and Pathology. Interleukin 3. Elsevier; 1988. pp. 281-311. [DOI: 10.1016/b978-0-12-432015-4.50013-x] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 442 |
Jacques Y, Paineau J, Chevalier S, Mauff B, Soulillou J. A study on OX39, a murine anti-rat interleukin 2 receptor antibody A report on receptor binding and effects on allograft survival. Transplant Int 1988;1:58-63. [DOI: 10.1111/j.1432-2277.1988.tb01784.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 443 |
Murphy JR. Diphtheria-related peptide hormone gene fusions: a molecular genetic approach to chimeric toxin development. Cancer Treat Res 1988;37:123-40. [PMID: 2908622 DOI: 10.1007/978-1-4613-1083-9_9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 444 |
Wano Y, Dukovich M, Greene WC, Kehrl JH. NEW PERSPECTIVES ON THE STRUCTURE OF THE HUMAN HIGH-AFFINITY INTERLEUKIN 2 RECEPTOR. Interleukin. Elsevier; 1988. pp. 99-112. [DOI: 10.1016/b978-0-12-651420-9.50010-5] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 445 |
Greene WC, Wano YJ, Dukovich M. New insights into the structure of high-affinity interleukin-2 receptors. Recent Prog Horm Res 1988;44:141-55. [PMID: 3064206 DOI: 10.1016/b978-0-12-571144-9.50009-0] [Reference Citation Analysis]
|
| 446 |
Smith KA. INTERLEUKIN 2: A 10-YEAR PERSPECTIVE. Interleukin. Elsevier; 1988. pp. 1-35. [DOI: 10.1016/b978-0-12-651420-9.50006-3] [Cited by in Crossref: 8] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 447 |
Palacios R, Karasuyama H, Rolink A. Ly1+ PRO-B lymphocyte clones. Phenotype, growth requirements and differentiation in vitro and in vivo. EMBO J 1987;6:3687-93. [PMID: 3501371 DOI: 10.1002/j.1460-2075.1987.tb02702.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 448 |
Horuk R, Huang J, Covington M, Newton R. A biochemical and kinetic analysis of the interleukin-1 receptor. Evidence for differences in molecular properties of IL-1 receptors. Journal of Biological Chemistry 1987;262:16275-8. [DOI: 10.1016/s0021-9258(18)49250-2] [Cited by in Crossref: 87] [Cited by in F6Publishing: 66] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 449 |
Pizzolo G, Chilosi M, Semenzato G. The soluble interleukin-2 receptor in haematological disorders. Br J Haematol 1987;67:377-80. [PMID: 3122815 DOI: 10.1111/j.1365-2141.1987.tb06156.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 450 |
Hakimi J, Seals C, Anderson LE, Podlaski FJ, Lin P, Danho W, Jenson JC, Perkins A, Donadio PE, Familletti PC. Biochemical and functional analysis of soluble human interleukin-2 receptor produced in rodent cells. Solid-phase reconstitution of a receptor-ligand binding reaction. Journal of Biological Chemistry 1987;262:17336-41. [DOI: 10.1016/s0021-9258(18)45382-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 451 |
Sia DY, Chou JL. In vivo activated lymphoid cells (IVALC) affect the cloning efficiency of human T lymphocytes reactive to a soluble antigen, purified protein derivative. Scand J Immunol 1987;26:683-90. [PMID: 3122312 DOI: 10.1111/j.1365-3083.1987.tb02304.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 452 |
Hardt C. Activation of murine CD8+ lymphocytes: two distinct signals regulate c-myc and interleukin 2 receptor RNA expression. Eur J Immunol 1987;17:1711-7. [PMID: 3121357 DOI: 10.1002/eji.1830171206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 453 |
Hovdenes J, Egeland T. Immunoregulatory lymphokines in rheumatoid joints. II. Production by and responsiveness to interleukin-2 of eluted synovial tissue cells. Rheumatol Int 1987;7:261-5. [PMID: 2964079 DOI: 10.1007/BF00270526] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 454 |
Sia DY. Immuno-modulation of human lymphocyte function by desferroxamine (Desferal). Immunopharmacology 1987;14:135-43. [PMID: 3127348 DOI: 10.1016/0162-3109(87)90011-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 455 |
R Palacios, H Karasuyama, A Rolink. Ly1+ PRO-B lymphocyte clones. Phenotype, growth requirements and differentiation in vitro and in vivo. EMBO J 1987;6. [PMID: 3501371] [Reference Citation Analysis]
|
| 456 |
Malkovský M, Sondel PM. Interleukin 2 and its receptor: structure, function and therapeutic potential. Blood Rev 1987;1:254-66. [PMID: 3332110 DOI: 10.1016/0268-960x(87)90027-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 457 |
Pizzolo G, Vinante F, Agostini C, Zambello R, Trentin L, Masciarelli M, Chilosi M, Benedetti F, Dazzi F, Todeschini G. Immunologic abnormalities in angioimmunoblastic lymphadenopathy. Cancer 1987;60:2412-8. [PMID: 2822218 DOI: 10.1002/1097-0142(19871115)60:10<2412::aid-cncr2820601010>3.0.co;2-f] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 458 |
Sakitani M, Nakamura M, Fujii M, Sugamura K, Hinuma Y. High affinity interleukin 2 receptors in HTLV-1-infected T cells can mediate signals for gene expression. Virus Genes 1987;1:35-47. [PMID: 3509878 DOI: 10.1007/BF00125684] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 459 |
Mouzaki A, Diamantstein T. Four epitopes on the rat 55-kDa subunit of the interleukin 2 receptor as defined by newly developed mouse anti-rat interleukin 2 receptor monoclonal antibodies. Eur J Immunol 1987;17:1661-4. [PMID: 2445587 DOI: 10.1002/eji.1830171123] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 460 |
Waldmann TA. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation. Environ Health Perspect 1987;75:11-5. [PMID: 2891501 DOI: 10.1289/ehp.877511] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 461 |
Ruzicka FJ, Jach ME, Borden EC. Binding of recombinant-produced interferon beta ser to human lymphoblastoid cells. Evidence for two binding domains. Journal of Biological Chemistry 1987;262:16142-9. [DOI: 10.1016/s0021-9258(18)47708-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 462 |
Siegel JP, Sharon M, Smith PL, Leonard WJ. The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. Science 1987;238:75-8. [PMID: 3116668 DOI: 10.1126/science.3116668] [Cited by in Crossref: 320] [Cited by in F6Publishing: 354] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 463 |
Szöllösi J, Damjanovich S, Goldman CK, Fulwyler MJ, Aszalos AA, Goldstein G, Rao P, Talle MA, Waldmann TA. Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide termed T27 with the 55-kDa Tac peptide. Proc Natl Acad Sci U S A 1987;84:7246-50. [PMID: 2444977 DOI: 10.1073/pnas.84.20.7246] [Cited by in Crossref: 69] [Cited by in F6Publishing: 83] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 464 |
Sterkers G, Huet S, Moachon L, Hu J, Boumsell L, Bernard A. Regulation of helper T cell clone proliferation via the CD2 molecule. Cell Immunol 1987;109:192-205. [PMID: 2958140 DOI: 10.1016/0008-8749(87)90304-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 465 |
Lowenthal JW, Greene WC. Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor. J Exp Med 1987;166:1156-61. [PMID: 3116145 DOI: 10.1084/jem.166.4.1156] [Cited by in Crossref: 103] [Cited by in F6Publishing: 127] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 466 |
Segarini PR, Roberts AB, Rosen DM, Seyedin SM. Membrane binding characteristics of two forms of transforming growth factor-beta. Journal of Biological Chemistry 1987;262:14655-62. [DOI: 10.1016/s0021-9258(18)47846-5] [Cited by in Crossref: 85] [Cited by in F6Publishing: 54] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 467 |
Trón L, Szöllösi J, Damjanovich S. Proximity measurements of cell surface proteins by fluorescence energy transfer. Immunol Lett 1987;16:1-9. [PMID: 3123374 DOI: 10.1016/0165-2478(87)90052-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 468 |
Taga T, Kawanishi Y, Hardy RR, Hirano T, Kishimoto T. Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression. J Exp Med 1987;166:967-81. [PMID: 2821154 DOI: 10.1084/jem.166.4.967] [Cited by in Crossref: 229] [Cited by in F6Publishing: 259] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 469 |
Dziarski R. Binding sites for peptidoglycan on mouse lymphocytes. Cell Immunol 1987;109:231-45. [PMID: 2820589 DOI: 10.1016/0008-8749(87)90307-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 470 |
Oh SK, Leung MF, Knee T, Williams JM. Biological properties of suppressive E-receptor factor on lymphokine function. Eur J Immunol 1987;17:1403-9. [PMID: 3119348 DOI: 10.1002/eji.1830171003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 471 |
Wang HM, Smith KA. The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med 1987;166:1055-69. [PMID: 3116143 DOI: 10.1084/jem.166.4.1055] [Cited by in Crossref: 290] [Cited by in F6Publishing: 353] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 472 |
Signore A, Parman A, Pozzilli P, Andreani D, Beverley PC. Detection of activated lymphocytes in endocrine pancreas of BB/W rats by injection of 123I-interleukin-2: an early sign of type 1 diabetes. Lancet 1987;2:537-40. [PMID: 2887834 DOI: 10.1016/s0140-6736(87)92925-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 473 |
Minami Y, Samelson LE, Klausner RD. Internalization and cycling of the T cell antigen receptor. Role of protein kinase C. Journal of Biological Chemistry 1987;262:13342-7. [DOI: 10.1016/s0021-9258(18)45206-4] [Cited by in Crossref: 103] [Cited by in F6Publishing: 102] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 474 |
Tanaka T, Saiki O, Doi S, Hatakeyama M, Doi T, Kono T, Mori H, Fujii M, Sugamura K, Negoro S. Functional interleukin 2 receptors on B cells lacking Tac antigens. Eur J Immunol 1987;17:1379-82. [PMID: 2820752 DOI: 10.1002/eji.1830170925] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 475 |
Vayuvegula B, Shimizu M, Gupta S. Autologous mixed lymphocyte reaction in man. XX. The cellular and molecular basis of deficient T-T AMLR in aging humans. Clin Immunol Immunopathol 1987;44:364-70. [PMID: 2957134 DOI: 10.1016/0090-1229(87)90080-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 476 |
Sugiyama M, Yamane H, Konishi K, Uekawa M, Tamura T, Nakai Y. Subsets of tonsillar lymphocytes and activated cells in each subset analysed by two-color flow cytometry. Acta Otolaryngol 1987;104:342-50. [PMID: 3499745 DOI: 10.3109/00016488709107338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 477 |
Herrmann T, Diamantstein T. The mouse high affinity IL 2 receptor complex. I. Evidence for a third molecule, the putative gamma-chain, associated with the alpha- and/or beta-chain of the receptor. Immunobiology 1987;175:145-58. [PMID: 3119468 DOI: 10.1016/s0171-2985(87)80024-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 478 |
Wickremasinghe RG, Mire-Sluis AR, Hoffbrand AV. Interleukin-2 binding to activated human T lymphocytes triggers generation of cyclic AMP but not of inositol phosphates. FEBS Lett 1987;220:52-6. [PMID: 3038615 DOI: 10.1016/0014-5793(87)80874-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 479 |
A B Reske-Kunz, T Diamantstein. Evaluation of antigen presentation by a murine Ia+ T-cell clone, BK-BI-2.6.C6. Immunology 1987;61. [PMID: 3127326] [Reference Citation Analysis]
|
| 480 |
Yoshihara PH, Thieme T, Finke P, Barney C, Tong A, Burger DR. Characterization of a T-cell determinant defined by a monoclonal antibody (TH5.2) which is involved in the interleukin-2-producing and proliferative capabilities of T cells. Cell Immunol 1987;108:10-27. [PMID: 3111721 DOI: 10.1016/0008-8749(87)90189-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 481 |
Chouaib S, Robb RJ, Welte K, Dupont B. Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate. J Clin Invest 1987;80:333-40. [PMID: 3038954 DOI: 10.1172/JCI113077] [Cited by in Crossref: 71] [Cited by in F6Publishing: 80] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 482 |
Levesque JP, Hatzfeld A, Hudry-Clergeon G, Wilner GD, Hatzfeld J. Evidence for two functionally different fibrinogen receptors on hemopoietic cells: the glycoprotein IIb-IIIa and the mitogenic fibrinogen receptor. J Cell Physiol 1987;132:303-10. [PMID: 3624317 DOI: 10.1002/jcp.1041320215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 483 |
Noble RL, Warren RP. Altered T-cell subsets and defective T-cell function in young children with Down syndrome (trisomy-21). Immunol Invest 1987;16:371-82. [PMID: 2961683 DOI: 10.3109/08820138709087092] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 484 |
Nel AE, Wooten MW, Galbraith RM. Molecular signaling mechanisms in T-lymphocyte activation pathways: a review and future prospects. Clin Immunol Immunopathol 1987;44:167-86. [PMID: 2440631 DOI: 10.1016/0090-1229(87)90064-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 485 |
Hatakeyama M, Doi T, Kono T, Maruyama M, Minamoto S, Mori H, Kobayashi M, Uchiyama T, Taniguchi T. Transmembrane signaling of interleukin 2 receptor. Conformation and function of human interleukin 2 receptor (p55)/insulin receptor chimeric molecules. J Exp Med 1987;166:362-75. [PMID: 3110352 DOI: 10.1084/jem.166.2.362] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 486 |
Tsudo M, Goldman CK, Bongiovanni KF, Chan WC, Winton EF, Yagita M, Grimm EA, Waldmann TA. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc Natl Acad Sci U S A 1987;84:5394-8. [PMID: 3110786 DOI: 10.1073/pnas.84.15.5394] [Cited by in Crossref: 123] [Cited by in F6Publishing: 160] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 487 |
Sakaguchi M, Koishihara Y, Tsuda H, Fujimoto K, Shibuya K, Kawakita M, Takatsuki K. The expression of functional erythropoietin receptors on an interleukin-3 dependent cell line. Biochem Biophys Res Commun 1987;146:7-12. [PMID: 3038112 DOI: 10.1016/0006-291x(87)90682-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 488 |
Palacios R, Kiefer M, Brockhaus M, Karjalainen K, Dembić Z, Kisielow P, von Boehmer H. Molecular, cellular, and functional properties of bone marrow T lymphocyte progenitor clones. J Exp Med 1987;166:12-32. [PMID: 3496413 DOI: 10.1084/jem.166.1.12] [Cited by in Crossref: 26] [Cited by in F6Publishing: 46] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 489 |
Stoeck M, Warncke U, Brennecke M, Resch K. Induction of responsiveness to interleukin 2 in mouse lymphocytes by synergistic action of ionophore A 23187 and diacylglycerol. Scand J Immunol 1987;26:85-9. [PMID: 3112932 DOI: 10.1111/j.1365-3083.1987.tb02238.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 490 |
P M Kaye. Acquisition of cell-mediated immunity to Leishmania. I. Primary T-cell activation detected by IL-2 receptor expression. Immunology 1987;61. [PMID: 3111982] [Reference Citation Analysis]
|
| 491 |
Moreau JL, Nabholz M, Diamantstein T, Malek T, Shevach E, Thèze J. Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site. Eur J Immunol 1987;17:929-35. [PMID: 2440696 DOI: 10.1002/eji.1830170706] [Cited by in Crossref: 70] [Cited by in F6Publishing: 77] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 492 |
P C Kwong, H S Teh. Mechanism of action of a Db-specific helper clone and factor in cytotoxic responses to alloantigens. Immunology 1987;61. [PMID: 2439444] [Reference Citation Analysis]
|
| 493 |
Tsudo M, Kozak RW, Goldman CK, Waldmann TA. Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex. Proc Natl Acad Sci U S A 1987;84:4215-8. [PMID: 3108887 DOI: 10.1073/pnas.84.12.4215] [Cited by in Crossref: 66] [Cited by in F6Publishing: 82] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 494 |
Nabholz M, Combe MC, Corthésy P, Lowenthal J, Gabathuler R. Interleukin 2 receptor traffic in a murine cytolytic T cell line. Eur J Immunol 1987;17:783-90. [PMID: 3109923 DOI: 10.1002/eji.1830170608] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 495 |
Skinner M, Le Gros G, Marbrook J, Watson JD. Development of fetal thymocytes in organ cultures. Effect of interleukin 2. J Exp Med 1987;165:1481-93. [PMID: 3108443 DOI: 10.1084/jem.165.6.1481] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 496 |
Le Mauff B, Gascan H, Olive D, Moreau JF, Mawas C, Soulillou JP, Jacques Y. Parameters of interaction of a novel monoclonal antibody (33B3.1) with the human IL2-receptors: interrelationship between 33B3.1, anti-Tac, and IL2 binding sites. Hum Immunol 1987;19:53-68. [PMID: 3034838 DOI: 10.1016/0198-8859(87)90038-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 497 |
Petersen CM, Christiansen BS, Kaltoft K. Binding, uptake and degradation of human recombinant interleukin-2 (125 ala) in activated human T- and B-lymphocytes and in monocyte-macrophages. Tissue Antigens 1987;29:257-72. [PMID: 3116720 DOI: 10.1111/j.1399-0039.1987.tb01585.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 498 |
Bowlin TL, McKown BJ, Babcock GF, Sunkara PS. Intracellular polyamine biosynthesis is required for interleukin 2 responsiveness during lymphocyte mitogenesis. Cell Immunol 1987;106:420-7. [PMID: 3105898 DOI: 10.1016/0008-8749(87)90184-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 499 |
MacDonald HR, Lowenthal JW. The interleukin-1/interleukin-1-receptor interaction. Ann Inst Pasteur Immunol 1987;138:482-5. [PMID: 2958019 DOI: 10.1016/s0769-2625(87)80062-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 500 |
Lakhanpal S, Gonchoroff NJ, Handwerger BS. Interleukin 2 induces proliferation of normal "resting" human T cells in the absence of other known external stimulation. Cell Immunol 1987;106:62-75. [PMID: 2952283 DOI: 10.1016/0008-8749(87)90150-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 501 |
Robb RJ, Rusk CM, Yodoi J, Greene WC. Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors. Proc Natl Acad Sci U S A 1987;84:2002-6. [PMID: 3031660 DOI: 10.1073/pnas.84.7.2002] [Cited by in Crossref: 139] [Cited by in F6Publishing: 187] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 502 |
Ju G, Collins L, Kaffka K, Tsien W, Chizzonite R, Crowl R, Bhatt R, Kilian P. Structure-function analysis of human interleukin-2. Identification of amino acid residues required for biological activity. Journal of Biological Chemistry 1987;262:5723-31. [DOI: 10.1016/s0021-9258(18)45635-9] [Cited by in Crossref: 105] [Cited by in F6Publishing: 105] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 503 |
Bernard O, Fazekas de St Groth B, Ullrich A, Green W, Schlessinger J. High-affinity interleukin 2 binding by an oncogenic hybrid interleukin 2-epidermal growth factor receptor molecule. Proc Natl Acad Sci U S A 1987;84:2125-9. [PMID: 3104909 DOI: 10.1073/pnas.84.8.2125] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 504 |
Georgoulias V, Allouche M, Salvatore A, Clemenceau C, Jasmin C. Interleukin 2 responsiveness of immature T-cell colony-forming cells (T-CFC) from patients with acute T-cell lymphoblastic leukemias. Cell Immunol 1987;105:317-31. [PMID: 3105894 DOI: 10.1016/0008-8749(87)90080-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 505 |
Robb RJ, Greene WC. Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor. J Exp Med 1987;165:1201-6. [PMID: 3031195 DOI: 10.1084/jem.165.4.1201] [Cited by in Crossref: 164] [Cited by in F6Publishing: 206] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 506 |
H J Horst, H D Flad. Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors. Clin Exp Immunol 1987;68. [PMID: 3115640] [Reference Citation Analysis]
|
| 507 |
Mouzaki A, Volk HD, Osawa H, Diamantstein T. Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18. Eur J Immunol 1987;17:335-41. [PMID: 3106058 DOI: 10.1002/eji.1830170306] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 508 |
Ishii T, Kohno M, Nakamura M, Hinuma Y, Sugamura K. Characterization of interleukin 2-stimulated phosphorylation of 67 and 63 kDa proteins in human T-cells. Biochem J 1987;242:211-9. [PMID: 3496080 DOI: 10.1042/bj2420211] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 509 |
Carrera AC, Sanchez-Madrid F, Lopez-Botet M, Bernabeu C, De Landazuri MO. Involvement of the CD4 molecule in a post-activation event on T cell proliferation. Eur J Immunol 1987;17:179-86. [PMID: 3104060 DOI: 10.1002/eji.1830170205] [Cited by in Crossref: 75] [Cited by in F6Publishing: 85] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 510 |
Nicolas JF, Kaiserlian D, Dardenne M, Faure M, Thivolet J. Epidermal cell-derived lymphocyte differentiating factor (ELDIF) inhibits in vitro lymphoproliferative responses and interleukin 2 production. J Invest Dermatol 1987;88:161-6. [PMID: 3100653 DOI: 10.1111/1523-1747.ep12525302] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 511 |
Waldmann TA. The interleukin-2 receptor on normal and malignant lymphocytes. Adv Exp Med Biol 1987;213:129-37. [PMID: 2888269 DOI: 10.1007/978-1-4684-5323-2_13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 512 |
Greene WC, Leonard WJ. Human interleukin 2 receptor (Tac antigen). Methods Enzymol 1987;150:682-700. [PMID: 3123879 DOI: 10.1016/0076-6879(87)50115-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 513 |
Kinashi T, Noma Y, Azuma C, Kondo S, Tanabe T, Konishi M, Kinoshita M, Takahashi M, Saito Y, Ogura T. Growth factors and receptors of lymphocytes. Acta Neurochir Suppl (Wien) 1987;41:118-25. [PMID: 2833074 DOI: 10.1007/978-3-7091-8945-0_16] [Reference Citation Analysis]
|
| 514 |
Bocci V. Metabolism of protein anticancer agents. Pharmacol Ther 1987;34:1-49. [PMID: 2443936 DOI: 10.1016/0163-7258(87)90090-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 515 |
Greene WC, Dukovich M, Wano Y, Kehrl JH, Robb RJ. The Human High Affinity Interleukin-2 Receptor. Molecular Basis of Lymphokine Action 1987. [DOI: 10.1007/978-1-4612-4598-8_16] [Reference Citation Analysis]
|
| 516 |
Teshigawara K, Wang HM, Kato K, Smith KA. Interleukin 2 high-affinity receptor expression requires two distinct binding proteins. J Exp Med 1987;165:223-38. [PMID: 3098894 DOI: 10.1084/jem.165.1.223] [Cited by in Crossref: 387] [Cited by in F6Publishing: 478] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 517 |
Iseki R, Koide Y, Ueda R, Kondo N, Hamuro J, Yoshida TO. The interaction of recombinant IL-2 with human resting lymphocytes: blocking effects of monoclonal antibodies to IL-2 receptors. Microbiol Immunol 1987;31:59-74. [PMID: 2438541 DOI: 10.1111/j.1348-0421.1987.tb03068.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 518 |
Faure GC, Bene MC, Bolle-Chanal MH. Expression of CD 25 (Tac antigen) in lymphoid leukemias and non-Hodgkin lymphomas. Eur J Haematol 1987;38:26-30. [PMID: 3034662 DOI: 10.1111/j.1600-0609.1987.tb01419.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 519 |
Luger TA, Smolen JS. The Role of Lymphokines in the Pathogenesis of Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 1987. [DOI: 10.1007/978-3-642-71642-3_10] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 520 |
Amento EP. Vitamin D and the immune system. Steroids 1987;49:55-72. [PMID: 3331847 DOI: 10.1016/0039-128x(87)90079-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 521 |
Waldmann TA, Kozak RW, Tsudo M, Oh-ishi T, Bongiovanni KF, Goldman CK. IL-2 receptors in adult T-cell leukemia: a target for immunotherapy. Haematol Blood Transfus 1987;31:110-5. [PMID: 3127278 DOI: 10.1007/978-3-642-72624-8_23] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 522 |
Sharon M, Leonard WJ. Identification of a Novel Interleukin-2 Receptor Subunit. Molecular Basis of Lymphokine Action 1987. [DOI: 10.1007/978-1-4612-4598-8_20] [Reference Citation Analysis]
|
| 523 |
Lunardi-Iskandar Y, Georgoulias V, Vittecoq D, Nugeyre MT, Ammar A, Clemenceau C, Barre-Sinoussi F, Chermann JC, Schwartzenberg L, Jasmin C. Peripheral blood adherent cells from AIDS patients inhibit normal T-colony growth through decreased expression of interleukin 2-receptors and production of interleukin 2. Leuk Res 1987;11:753-60. [PMID: 3114567 DOI: 10.1016/0145-2126(87)90013-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 524 |
Chin J, Cameron PM, Rupp E, Schmidt JA. Identification of a high-affinity receptor for native human interleukin 1 beta and interleukin 1 alpha on normal human lung fibroblasts. J Exp Med 1987;165:70-86. [PMID: 2947968 DOI: 10.1084/jem.165.1.70] [Cited by in Crossref: 106] [Cited by in F6Publishing: 121] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 525 |
Saneto RP, Chiappelli F, de Vellis J. Interleukin-2 inhibition of oligodendrocyte progenitor cell proliferation depends on expression of the TAC receptor. J Neurosci Res 1987;18:147-54. [PMID: 3500322 DOI: 10.1002/jnr.490180122] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 526 |
Pizzolo G, Trentin L, Vinante F, Agostini C, Zambello R, Ranucci A, Luca M, Chilosi M, Dazzi F, Foa R. Rearrangement for the T-cell receptor gene and co-expression of immature T-cell markers and natural killer cell phenotype, in a patient with acute lymphoblastic leukaemia. Br J Haematol 1987;65:17-22. [PMID: 3493027 DOI: 10.1111/j.1365-2141.1987.tb06129.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 527 |
R Palacios, P Sideras, H von Boehmer. Recombinant interleukin 4/BSF-1 promotes growth and differentiation of intrathymic T cell precursors from fetal mice in vitro. EMBO J 1987;6. [PMID: 3495433] [Reference Citation Analysis]
|
| 528 |
Marcus DM, Dustira A, Diego I, Osovitz S, Lewis DE. Studies of the mechanism by which gangliosides inhibit the proliferative response of murine splenocytes to concanavalin A. Cell Immunol 1987;104:71-8. [PMID: 3100066 DOI: 10.1016/0008-8749(87)90007-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 529 |
Defreitas EC, Sandberg-wolheim M, Koprowski H. IL-2 Receptor Expression on T Cell Lines Derived from Peripheral Blood and Cerebrospinal Fluid of Multiple Sclerosis Patients. Cellular and Humoral Immunological Components of Cerebrospinal Fluid in Multiple Sclerosis 1987. [DOI: 10.1007/978-1-4899-5348-3_36] [Reference Citation Analysis]
|
| 530 |
Yamaguchi A, Uede T, Murakami T, Osawa H, Diamantstein T, Kikuchi K. Biological Significance of Interleukin 2 Receptor Associated Molecules. Molecular Basis of Lymphokine Action 1987. [DOI: 10.1007/978-1-4612-4598-8_19] [Reference Citation Analysis]
|
| 531 |
Smith KA. The two-chain structure of high-affinity IL-2 receptors. Immunology Today 1987;8:11-3. [DOI: 10.1016/0167-5699(87)90824-3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 532 |
Ward SG, Lewis GP, Westwick J. A Role for Platelet-Activating Factor (PAF) in Human T-Lymphocyte Proliferation. In: Paubert-braquet M, Braquet P, Demling B, Fletcher JR, Foegh M, editors. Lipid Mediators in the Immunology of Shock. Boston: Springer US; 1988. pp. 483-93. [DOI: 10.1007/978-1-4613-0919-2_52] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 533 |
Forni G, Giovarelli M, Santoni A, Modesti A, Forni M. Tumour inhibition by interleukin-2 at the tumour/host interface. Biochim Biophys Acta 1986;865:307-27. [PMID: 3539200 DOI: 10.1016/0304-419x(86)90020-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 534 |
Chanda PK, Chen GF, Baine Y, Leonard WJ, Greene WC, Chang TW, Chang NT. Expression of human interleukin-2 receptor cDNA in E. coli. Biochem Biophys Res Commun 1986;141:804-11. [PMID: 3026392 DOI: 10.1016/s0006-291x(86)80244-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 535 |
Lowenthal JW, Link L, Hashimoto N, Zubler RH. B cell receptors for interleukin 2: demonstration of IL2 internalization and of complementary effects of lipopolysaccharide and phorbol diester on receptor expression. Eur J Immunol 1986;16:1591-5. [PMID: 3102248 DOI: 10.1002/eji.1830161219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 536 |
Hatakeyama M, Minamoto S, Taniguchi T. Intracytoplasmic phosphorylation sites of Tac antigen (p55) are not essential for the conformation, function, and regulation of the human interleukin 2 receptor. Proc Natl Acad Sci U S A 1986;83:9650-4. [PMID: 3099287 DOI: 10.1073/pnas.83.24.9650] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 537 |
D A Shackelford, I S Trowbridge. Evidence for two extracellular domains in the human interleukin-2 receptor: localization of IL-2 binding. EMBO J 1986;5. [PMID: 3102228] [Reference Citation Analysis]
|
| 538 |
Faltynek CR, Princler GL. Modulation of interferon-alpha and interferon-gamma receptor expression during T-lymphocyte activation and proliferation. J Interferon Res 1986;6:639-53. [PMID: 2952737 DOI: 10.1089/jir.1986.6.639] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 539 |
Kondo S, Shimizu A, Saito Y, Kinoshita M, Honjo T. Molecular basis for two different affinity states of the interleukin 2 receptor: affinity conversion model. Proc Natl Acad Sci U S A 1986;83:9026-9. [PMID: 3097640 DOI: 10.1073/pnas.83.23.9026] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 540 |
Tsudo M, Kozak RW, Goldman CK, Waldmann TA. Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci U S A 1986;83:9694-8. [PMID: 3099289 DOI: 10.1073/pnas.83.24.9694] [Cited by in Crossref: 257] [Cited by in F6Publishing: 341] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 541 |
Namiuchi S, Kumagai S, Sano H, Yodoi J, Uchiyama T, Ikai K, Imura H, Maeda M. A human T cell line established from a patient with Sézary syndrome. Application for assay of human interleukin 2 (IL-2). J Immunol Methods 1986;94:215-24. [PMID: 3023492 DOI: 10.1016/0022-1759(86)90236-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 542 |
Lowenthal JW, MacDonald HR, Iacopetta BJ. Intracellular pathway of interleukin 2 following receptor-mediated endocytosis. Eur J Immunol 1986;16:1461-3. [PMID: 3096748 DOI: 10.1002/eji.1830161125] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 543 |
Diamantstein T, Osawa H, Mouzaki A, Josimovic-Alasevic O. Regulation of interleukin-2 receptor expression and receptor release. Mol Immunol 1986;23:1165-72. [PMID: 3102950 DOI: 10.1016/0161-5890(86)90147-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 544 |
Duprez V, Dautry-varsat A. Receptor-mediated endocytosis of interleukin 2 in a human tumor T cell line. Degradation of interleukin 2 and evidence for the absence of recycling of interleukin receptors. Journal of Biological Chemistry 1986;261:15450-4. [DOI: 10.1016/s0021-9258(18)66732-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 545 |
Siliciano RF, Hemesath TJ, Pratt JC, Dintzis RZ, Dintzis HM, Acuto O, Shin HS, Reinherz EL. Direct evidence for the existence of nominal antigen binding sites on T cell surface Ti alpha-beta heterodimers of MHC-restricted T cell clones. Cell 1986;47:161-71. [PMID: 2945646 DOI: 10.1016/0092-8674(86)90439-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 64] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 546 |
Lowenthal JW, MacDonald HR. Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor. J Exp Med 1986;164:1060-74. [PMID: 2944981 DOI: 10.1084/jem.164.4.1060] [Cited by in Crossref: 146] [Cited by in F6Publishing: 165] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 547 |
C M Roifman, G B Mills, R K Cheung, E W Gelfand. Mitogenic response of human thymocytes: identification of functional Ca2+-dependent and independent signals. Clin Exp Immunol 1986;66. [PMID: 3100117] [Reference Citation Analysis]
|
| 548 |
Grausz JD, Fradelizi D, Dautry F, Monier R, Lehn P. Modulation of c-fos and c-myc mRNA levels in normal human lymphocytes by calcium ionophore A23187 and phorbol ester. Eur J Immunol 1986;16:1217-21. [PMID: 3095123 DOI: 10.1002/eji.1830161006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 549 |
Kaplan DR. A novel mechanism of immunosuppression mediated by ethanol. Cell Immunol 1986;102:1-9. [PMID: 3100053 DOI: 10.1016/0008-8749(86)90320-5] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 550 |
J A Teodorczyk-Injeyan, B G Sparkes, G B Mills, W J Peters, R E Falk. Impairment of T cell activation in burn patients: a possible mechanism of thermal injury-induced immunosuppression. Clin Exp Immunol 1986;65. [PMID: 2946498] [Reference Citation Analysis]
|
| 551 |
Panayotides P, Lenkei R, Porwit A, Reizenstein P. Malignant B-cells have receptors for and respond to interleukin-2. Med Oncol Tumor Pharmacother 1986;3:255-63. [PMID: 3100885 DOI: 10.1007/BF02935002] [Reference Citation Analysis]
|
| 552 |
Dohlsten M, Sjögren HO, Carlsson R. Histamine inhibits interferon-gamma production via suppression of interleukin 2 synthesis. Cell Immunol 1986;101:493-501. [PMID: 2944612 DOI: 10.1016/0008-8749(86)90160-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 553 |
Larsson EL. Interleukin-2 (IL-2) and its receptor. Med Oncol Tumor Pharmacother 1986;3:231-6. [PMID: 3100883 DOI: 10.1007/BF02934999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 554 |
Isakov N, Scholz W, Altman A. Signal transduction and intracellular events in T-lymphocyte activation. Immunology Today 1986;7:271-7. [DOI: 10.1016/0167-5699(86)90009-5] [Cited by in Crossref: 115] [Cited by in F6Publishing: 97] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 555 |
Levesque JP, Hatzfeld A, Hatzfeld J. Fibrinogen mitogenic effect on hemopoietic cell lines: control via receptor modulation. Proc Natl Acad Sci U S A 1986;83:6494-8. [PMID: 3018735 DOI: 10.1073/pnas.83.17.6494] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 556 |
Callard RE, Smith SH, Shields JG, Levinsky RJ. T cell help in human antigen-specific antibody responses can be replaced by interleukin 2. Eur J Immunol 1986;16:1037-42. [PMID: 3019704 DOI: 10.1002/eji.1830160902] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 557 |
Friedrich B, Lundström M, Gullberg M. Interleukin-2 versus phorbol-ester-induced cellular events in normal T-lymphocytes. Med Oncol Tumor Pharmacother 1986;3:237-46. [PMID: 3100884 DOI: 10.1007/BF02935000] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 558 |
Greene WC. Characterization of the human interleukin 2 receptor at the DNA, RNA, and protein level. Immunobiology 1986;172:357-64. [PMID: 3100432 DOI: 10.1016/S0171-2985(86)80117-6] [Reference Citation Analysis]
|
| 559 |
Cosman D, Wignall J, Lewis A, Alpert A, Cerretti DP, Park L, Dower SK, Gillis S, Urdal DL. High level stable expression of human interleukin-2 receptors in mouse cells generates only low affinity interleukin-2 binding sites. Mol Immunol 1986;23:935-41. [PMID: 3097520 DOI: 10.1016/0161-5890(86)90123-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 560 |
M Gullberg. Structural analysis of high- versus low-affinity interleukin-2 receptors by means of selective expression of distinct receptor classes. EMBO J 1986;5. [PMID: 3096717] [Reference Citation Analysis]
|
| 561 |
Osawa H, Josimovic-Alasevic O, Diamantstein T. Enzyme-linked immunosorbent assay of mouse interleukin-2 receptors. J Immunol Methods 1986;92:109-15. [PMID: 3091697 DOI: 10.1016/0022-1759(86)90510-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 562 |
Shimizu A, Kondo S, Sabe H, Ishida N, Honjo T. Structure and function of the interleukin 2 receptor: affinity conversion model. Immunol Rev 1986;92:103-20. [PMID: 3091479 DOI: 10.1111/j.1600-065x.1986.tb01496.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 563 |
Greene WC, Depper JM, Krönke M, Leonard WJ. The human interleukin-2 receptor: analysis of structure and function. Immunol Rev 1986;92:29-48. [PMID: 3091481 DOI: 10.1111/j.1600-065x.1986.tb01492.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 564 |
Habu S. IL 2 receptor expression on differentiating lymphocytes in the murine thymocyte. Immunol Rev 1986;92:67-80. [PMID: 3091484 DOI: 10.1111/j.1600-065x.1986.tb01494.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 565 |
Malek TR, Ashwell JD, Germain RN, Shevach EM, Miller J. The murine interleukin-2 receptor: biochemical structure and regulation of expression. Immunol Rev 1986;92:81-101. [PMID: 3091485 DOI: 10.1111/j.1600-065x.1986.tb01495.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 566 |
Gelfand EW, Cheung RK, Grinstein S, Mills GB. Characterization of the role for calcium influx in mitogen-induced triggering of human T cells. Identification of calcium-dependent and calcium-independent signals. Eur J Immunol 1986;16:907-12. [PMID: 3091377 DOI: 10.1002/eji.1830160806] [Cited by in Crossref: 66] [Cited by in F6Publishing: 75] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 567 |
Sztein MB, Serrate SA, Goldstein AL. Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones. Proc Natl Acad Sci U S A 1986;83:6107-11. [PMID: 3090550 DOI: 10.1073/pnas.83.16.6107] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 568 |
Taniguchi T, Matsui H, Fujita T, Hatakeyama M, Kashima N, Fuse A, Hamuro J, Nishi-Takaoka C, Yamada G. Molecular analysis of the interleukin-2 system. Immunol Rev 1986;92:121-33. [PMID: 3091480 DOI: 10.1111/j.1600-065x.1986.tb01497.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 73] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 569 |
Farrar WL, Cleveland JL, Beckner SK, Bonvini E, Evans SW. Biochemical and molecular events associated with interleukin 2 regulation of lymphocyte proliferation. Immunol Rev 1986;92:49-65. [PMID: 3091482 DOI: 10.1111/j.1600-065x.1986.tb01493.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 570 |
Sabath DE, Monos DS, Lee SC, Deutsch C, Prystowsky MB. Cloned T-cell proliferation and synthesis of specific proteins are inhibited by quinine. Proc Natl Acad Sci U S A 1986;83:4739-43. [PMID: 2425353 DOI: 10.1073/pnas.83.13.4739] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 571 |
E C Ebert, A I Roberts, R E Brolin, K Raska. Examination of the low proliferative capacity of human jejunal intraepithelial lymphocytes. Clin Exp Immunol 1986;65. [PMID: 2947761] [Reference Citation Analysis]
|
| 572 |
Reske-Kunz AB, von Steldern D, Rüde E, Diamantstein T. Regulation of interleukin 2 receptor expression by interleukin 2. Scand J Immunol 1986;23:693-701. [PMID: 3086969 DOI: 10.1111/j.1365-3083.1986.tb02006.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 573 |
Weyand CM, Goronzy J, Dallman MJ, Fathman CG. Administration of recombinant interleukin 2 in vivo induces a polyclonal IgM response. J Exp Med 1986;163:1607-12. [PMID: 3486940 DOI: 10.1084/jem.163.6.1607] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 574 |
Havran WL, Kim DK, Moldwin RL, Lancki DW, Fitch FW. Interleukin-2 differentially regulates IL-2 receptors on murine cloned cytolytic and helper T cells. Clin Immunol Immunopathol 1986;39:368-78. [PMID: 2938859 DOI: 10.1016/0090-1229(86)90165-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 575 |
W A Ofosu-Appiah, R M McKenna, R J Warrington, J A Wilkins. Characterization of synovial T lymphocytes in rheumatoid arthritis. I. Production of IL-2 dependent T cell clones from synovial fluid and peripheral blood. Clin Exp Immunol 1986;64. [PMID: 3491696] [Reference Citation Analysis]
|
| 576 |
Shackelford DA, Trowbridge IS. Identification of lymphocyte integral membrane proteins as substrates for protein kinase C. Phosphorylation of the interleukin-2 receptor, class I HLA antigens, and T200 glycoprotein. Journal of Biological Chemistry 1986;261:8334-41. [DOI: 10.1016/s0021-9258(19)83917-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 577 |
Olive D, Raymond J, Dubreuil P, Charmot D, Jacques Y, Mawas C. Anti-interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody-receptor interactions in their antagonist effects on interleukin 2-dependent T cell growth. Eur J Immunol 1986;16:611-6. [PMID: 2424766 DOI: 10.1002/eji.1830160605] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 578 |
Robb RJ. Conversion of low-affinity interleukin 2 receptors to a high-affinity state following fusion of cell membranes. Proc Natl Acad Sci U S A 1986;83:3992-6. [PMID: 3086875 DOI: 10.1073/pnas.83.11.3992] [Cited by in Crossref: 40] [Cited by in F6Publishing: 51] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 579 |
Greene WC, Leonard WJ, Wano Y, Svetlik PB, Peffer NJ, Sodroski JG, Rosen CA, Goh WC, Haseltine WA. Trans-activator gene of HTLV-II induces IL-2 receptor and IL-2 cellular gene expression. Science 1986;232:877-80. [PMID: 3010456 DOI: 10.1126/science.3010456] [Cited by in Crossref: 102] [Cited by in F6Publishing: 111] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 580 |
Waldmann TA. The interleukin-2 receptor on malignant cells: a target for diagnosis and therapy. Cell Immunol 1986;99:53-60. [PMID: 3019574 DOI: 10.1016/0008-8749(86)90215-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 581 |
Lê thi Bich-Thuy, Fauci AS. Recombinant interleukin 2 and gamma-interferon act synergistically on distinct steps of in vitro terminal human B cell maturation. J Clin Invest 1986;77:1173-9. [PMID: 3082936 DOI: 10.1172/JCI112418] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 582 |
Bich-Thuy LT, Lane HC, Fauci AS. Recombinant interleukin-2-induced polyclonal proliferation of in vitro unstimulated human peripheral blood lymphocytes. Cell Immunol 1986;98:396-410. [PMID: 3019569 DOI: 10.1016/0008-8749(86)90299-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 583 |
Ohike Y, Imai M, Tanaka E, Mukaida N, Kasahara T, Tachibana K, Miyakawa Y, Mayumi M. A radioimmunoassay that sandwiches human interleukin-2 between radiolabeled monoclonal antibody and the receptor on a hematopoietic cell line. J Immunol Methods 1986;87:245-9. [PMID: 3005419 DOI: 10.1016/0022-1759(86)90538-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 584 |
Kondo S, Shimizu A, Maeda M, Tagaya Y, Yodoi J, Honjo T. Expression of functional human interleukin-2 receptor in mouse T cells by cDNA transfection. Nature 1986;320:75-7. [PMID: 3081815 DOI: 10.1038/320075a0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 585 |
Fujii M, Sugamura K, Sano K, Nakai M, Sugita K, Hinuma Y. High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells. J Exp Med 1986;163:550-62. [PMID: 3005464 DOI: 10.1084/jem.163.3.550] [Cited by in Crossref: 130] [Cited by in F6Publishing: 166] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 586 |
Weissman AM, Harford JB, Svetlik PB, Leonard WL, Depper JM, Waldmann TA, Greene WC, Klausner RD. Only high-affinity receptors for interleukin 2 mediate internalization of ligand. Proc Natl Acad Sci U S A 1986;83:1463-6. [PMID: 3081898 DOI: 10.1073/pnas.83.5.1463] [Cited by in Crossref: 101] [Cited by in F6Publishing: 127] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 587 |
Triebel F, de Roquefeuil S, Blanc C, Charron DJ, Debre P. Expression of MHC class II and Tac antigens on IL2-activated human T cell clones that can stimulate in MLR, AMLR, PLT and can present antigen. Hum Immunol 1986;15:302-15. [PMID: 2420767 DOI: 10.1016/0198-8859(86)90005-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 588 |
Kosmatopoulos C, Allouche M, Triebel F, Zanti M, Clemenceau C, Gluckman JC, Jasmin C, Georgoulias V. Media conditioned by human leukemic T-cells induce expression of IL2 receptors and proliferation of normal T lymphocytes. Int J Cancer 1986;37:247-53. [PMID: 2417965 DOI: 10.1002/ijc.2910370213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 589 |
Polke CR, Lowenthal JW, Roth SA, Rohwer P, MacDonald HR, Kalden JR. Phorbol ester enhances both interleukin 2 receptor expression and immunoglobulin secretion in human Epstein-Barr virus-immortalized B cells. Eur J Immunol 1986;16:146-50. [PMID: 3007165 DOI: 10.1002/eji.1830160207] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 590 |
Palacios R, Von Boehmer H. Requirements for growth of immature thymocytes from fetal and adult mice in vitro. Eur J Immunol 1986;16:12-9. [PMID: 3081352 DOI: 10.1002/eji.1830160104] [Cited by in Crossref: 58] [Cited by in F6Publishing: 68] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 591 |
N Mukaida, T Kasahara, J Hosoi, K Shioiri-Nakano, T Kawai. Effects of anti-Tac antibody on the response of large granular lymphocytes to interleukin-2. Immunology 1986;57. [PMID: 3002967] [Reference Citation Analysis]
|
| 592 |
Isakov N, Altman A. Interleukin 2, an Immunoregulatory hormone. Clinical Immunology Newsletter 1986;7:1-4. [DOI: 10.1016/0197-1859(86)90028-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 593 |
Roosnek EE, Brouwer MC, Kipp JB, Aarden LA. Monocyte-dependent induction of proliferation of human peripheral T cells by recombinant interleukin 2. Eur J Immunol 1986;16:35-40. [PMID: 3081354 DOI: 10.1002/eji.1830160108] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 594 |
H Sano, S Kumagai, S Namiuchi, T Uchiyama, J Yodoi, M Maeda, K Takatsuki, T Suginoshita, H Imura. Systemic lupus erythematosus sera antilymphocyte reactivity: detection of antibodies to Tac-antigen positive T cell lines. Clin Exp Immunol 1986;63. [PMID: 3006953] [Reference Citation Analysis]
|
| 595 |
Hatakeyama M, Minamoto S, Mori H, Taniguchi T. Structure and Function of the Human Interleukin-2 Receptor. Oncogenes and Growth Control 1986. [DOI: 10.1007/978-3-642-73325-3_18] [Reference Citation Analysis]
|
| 596 |
Yamada G, Fujita T, Hatakeyama M, Taniguchi T. Molecular Biology of Interleukin-2 and Its Receptor: The Current Status. Progress in Immunology 1986. [DOI: 10.1016/b978-0-12-174685-8.50049-4] [Reference Citation Analysis]
|
| 597 |
Gupta S. Study of activated T cells in man. II. Interleukin 2 receptor and transferrin receptor expression on T cells and production of interleukin 2 in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Clin Immunol Immunopathol 1986;38:93-100. [PMID: 3000665 DOI: 10.1016/0090-1229(86)90126-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 598 |
Waldmann TA, Kozak RW, Tsudo M, Oh-ishi T, Bongiovanni KF, Goldman CK. Role and Molecular Biology of the Interleukin–2-Interleukin-2 Receptor System in Health and Disease. Progress in Immunology 1986. [DOI: 10.1016/b978-0-12-174685-8.50057-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 599 |
Arya SK, Sarngadharan MG. T-Cell Growth Factor (Interleukin-2). New Experimental Modalities in the Control of Neoplasia 1986. [DOI: 10.1007/978-1-4684-5242-6_11] [Reference Citation Analysis]
|
| 600 |
Hatakeyama M, Minamoto S, Uchiyama T, Hardy RR, Yamada G, Taniguchi T. Reconstitution of functional receptor for human interleukin-2 in mouse cells. Nature 1985;318:467-70. [PMID: 3934560 DOI: 10.1038/318467a0] [Cited by in Crossref: 105] [Cited by in F6Publishing: 127] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 601 |
Reem GH, Yeh NH, Urdal DL, Kilian PL, Farrar JJ. Induction and upregulation by interleukin 2 of high-affinity interleukin 2 receptors on thymocytes and T cells. Proc Natl Acad Sci U S A 1985;82:8663-6. [PMID: 3936041 DOI: 10.1073/pnas.82.24.8663] [Cited by in Crossref: 26] [Cited by in F6Publishing: 34] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 602 |
Kehrl JH, Muraguchi A, Goldsmith PK, Fauci AS. The direct effects of interleukin 1, interleukin 2, interferon-alpha, interferon-gamma, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells. Cell Immunol 1985;96:38-48. [PMID: 2424621 DOI: 10.1016/0008-8749(85)90338-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 603 |
Duprez V, Lenoir G, Dautry-Varsat A. Autocrine growth stimulation of a human T-cell lymphoma line by interleukin 2. Proc Natl Acad Sci U S A 1985;82:6932-6. [PMID: 3931081 DOI: 10.1073/pnas.82.20.6932] [Cited by in Crossref: 49] [Cited by in F6Publishing: 67] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 604 |
Minato N, Amagai T, Yodoi J, Diamanstein T, Kano S. Regulation of the growth and functions of cloned murine large granular lymphocyte lines by resident macrophages. J Exp Med 1985;162:1161-81. [PMID: 3930651 DOI: 10.1084/jem.162.4.1161] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 605 |
Leonard WJ, Krönke M, Peffer NJ, Depper JM, Greene WC. Interleukin 2 receptor gene expression in normal human T lymphocytes. Proc Natl Acad Sci U S A 1985;82:6281-5. [PMID: 3929255 DOI: 10.1073/pnas.82.18.6281] [Cited by in Crossref: 111] [Cited by in F6Publishing: 133] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 606 |
Ford RJ, Yoshimura L, Morgan J, Quesada J, Montagna R, Maizel A. Growth factor-mediated tumor cell proliferation in hairy cell leukemia. J Exp Med 1985;162:1093-8. [PMID: 2993470 DOI: 10.1084/jem.162.3.1093] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 607 |
Uchiyama T, Hori T, Tsudo M, Wano Y, Umadome H, Tamori S, Yodoi J, Maeda M, Sawami H, Uchino H. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J Clin Invest 1985;76:446-53. [PMID: 2993359 DOI: 10.1172/JCI111992] [Cited by in Crossref: 153] [Cited by in F6Publishing: 171] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 608 |
Robb RJ, Mayer PC, Garlick R. Retention of biological activity following radioiodination of human interleukin 2: comparison with biosynthetically labeled growth factor in receptor binding assays. J Immunol Methods 1985;81:15-30. [PMID: 3926900 DOI: 10.1016/0022-1759(85)90118-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 609 |
Greene WC, Robb RJ, Svetlik PB, Rusk CM, Depper JM, Leonard WJ. Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells. J Exp Med 1985;162:363-8. [PMID: 2989411 DOI: 10.1084/jem.162.1.363] [Cited by in Crossref: 84] [Cited by in F6Publishing: 107] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 610 |
Lowenthal JW, Zubler RH, Nabholz M, MacDonald HR. Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. Nature 1985;315:669-72. [PMID: 3925347 DOI: 10.1038/315669a0] [Cited by in Crossref: 145] [Cited by in F6Publishing: 156] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 611 |
Depper JM, Leonard WJ, Drogula C, Krönke M, Waldmann TA, Greene WC. Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci U S A 1985;82:4230-4. [PMID: 2987968 DOI: 10.1073/pnas.82.12.4230] [Cited by in Crossref: 161] [Cited by in F6Publishing: 205] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 612 |
Schwarting R, Welte K, Chiorazzi N, Ralph P, Lane CL, Long C, Wang CY. Biochemical characterization and purification of human B cell stimulatory factor (BSF). Eur J Immunol 1985;15:632-7. [PMID: 3874076 DOI: 10.1002/eji.1830150619] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 613 |
Lugo JP, Krishnan SN, Sailor RD, Koen P, Malek T, Rothenberg E. Proliferation of thymic stem cells with and without receptors for interleukin 2. Implications for intrathymic antigen recognition. J Exp Med 1985;161:1048-62. [PMID: 3921650 DOI: 10.1084/jem.161.5.1048] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 614 |
Michalski JP, McCombs CC. Reduction of excessive background counts in an IL-2 microassay by incubation of indicator cells at 37 degrees C. J Immunol Methods 1985;78:159-60. [PMID: 3872334 DOI: 10.1016/0022-1759(85)90339-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 615 |
Ceredig R, Lowenthal JW, Nabholz M, MacDonald HR. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature 1985;314:98-100. [PMID: 3919312 DOI: 10.1038/314098a0] [Cited by in Crossref: 432] [Cited by in F6Publishing: 478] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 616 |
M Spitz, A Gearing, M Callus, L Spitz, R Thorpe. Interleukin-2 in vivo: production of and response to interleukin-2 in lymphoid organs undergoing a primary immune response to heterologous erythrocytes. Immunology 1985;54. [PMID: 3871732] [Reference Citation Analysis]
|
| 617 |
Gupta S. Interleukins. In: Gupta S, Talal N, editors. Immunology of Rheumatic Diseases. Boston: Springer US; 1985. pp. 109-39. [DOI: 10.1007/978-1-4613-2493-5_4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 618 |
Knobloch C, Schlesier M, Dräger R, Gärtner M, Peter HH. Quantitative absorption of interleukin-2 by peripheral blood and synovial fluid lymphocytes from patients with rheumatoid arthritis. Rheumatol Int 1985;5:133-9. [PMID: 3925539 DOI: 10.1007/BF00541333] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 619 |
Nabholz M. The Mechanisms That Control the Proliferation and Activity of Cytolytic T Lymphocytes. Hybridoma Technology in the Biosciences and Medicine 1985. [DOI: 10.1007/978-1-4684-4964-8_34] [Reference Citation Analysis]
|
| 620 |
Robb RJ. Human interleukin 2. Methods Enzymol 1985;116:493-525. [PMID: 3937027 DOI: 10.1016/s0076-6879(85)16040-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 0.6] [Reference Citation Analysis]
|
